Submit Search
Upload
2012 sirisamut j health sc_evaluation of outcomes and determinants of cervical cancer screening in th_2005-9
•
1 like
•
228 views
Chuchai Sornchumni
Follow
ชวนกันตรวจคัดกรองมะเร็งปากมดลูกเพื่อสุขภาวะของชาติ
Read less
Read more
Healthcare
Report
Share
Report
Share
1 of 19
Download now
Download to read offline
Recommended
TSMT Journal03 (วารสาร สควค. ฉบับที่ 3)
TSMT Journal03 (วารสาร สควค. ฉบับที่ 3)
SAKANAN ANANTASOOK
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
Utai Sukviwatsirikul
143.irritable bowel syndrome (guideline 2012)
143.irritable bowel syndrome (guideline 2012)
Aimmary
Cough guideline 2016
Cough guideline 2016
Utai Sukviwatsirikul
Cpg กรดไหลย้อนในเด็ก
Cpg กรดไหลย้อนในเด็ก
Utai Sukviwatsirikul
Cpg childhood obstructive sleep apnea
Cpg childhood obstructive sleep apnea
Utai Sukviwatsirikul
Correct English:9789740326281
Correct English:9789740326281
CUPress
宋代《演雅》诗研究
宋代《演雅》诗研究
sugeladi
Recommended
TSMT Journal03 (วารสาร สควค. ฉบับที่ 3)
TSMT Journal03 (วารสาร สควค. ฉบับที่ 3)
SAKANAN ANANTASOOK
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
Utai Sukviwatsirikul
143.irritable bowel syndrome (guideline 2012)
143.irritable bowel syndrome (guideline 2012)
Aimmary
Cough guideline 2016
Cough guideline 2016
Utai Sukviwatsirikul
Cpg กรดไหลย้อนในเด็ก
Cpg กรดไหลย้อนในเด็ก
Utai Sukviwatsirikul
Cpg childhood obstructive sleep apnea
Cpg childhood obstructive sleep apnea
Utai Sukviwatsirikul
Correct English:9789740326281
Correct English:9789740326281
CUPress
宋代《演雅》诗研究
宋代《演雅》诗研究
sugeladi
Gram Eng Easy:9789740326366
Gram Eng Easy:9789740326366
CUPress
รายงานประจำปี 2548
รายงานประจำปี 2548
L.P.N. Development PCL.
Chandrayaanam
Chandrayaanam
Balu Bold
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNB Group
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNB Group
Rbi banking
Rbi banking
Chand Rook
Ph10 pa-004
Ph10 pa-004
DARSRADAR
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
Eneutron
Vaakkiyam amaittal 2012
Vaakkiyam amaittal 2012
Raja Segaran
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
Eneutron
Vro model paper
Vro model paper
krishna_t
Grama revenue paripalana_margadarshini
Grama revenue paripalana_margadarshini
bansi default
Code of sales PReMA 2010
Code of sales PReMA 2010
Utai Sukviwatsirikul
Qawaa Id Al Mouslaa
Qawaa Id Al Mouslaa
Abousalimata
Ph10 pa-003
Ph10 pa-003
DARSRADAR
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNB Group
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
Utai Sukviwatsirikul
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
DMS Library
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
Utai Sukviwatsirikul
Cough guideline 2016
Cough guideline 2016
Utai Sukviwatsirikul
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Utai Sukviwatsirikul
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Utai Sukviwatsirikul
More Related Content
What's hot
Gram Eng Easy:9789740326366
Gram Eng Easy:9789740326366
CUPress
รายงานประจำปี 2548
รายงานประจำปี 2548
L.P.N. Development PCL.
Chandrayaanam
Chandrayaanam
Balu Bold
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNB Group
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNB Group
Rbi banking
Rbi banking
Chand Rook
Ph10 pa-004
Ph10 pa-004
DARSRADAR
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
Eneutron
Vaakkiyam amaittal 2012
Vaakkiyam amaittal 2012
Raja Segaran
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
Eneutron
Vro model paper
Vro model paper
krishna_t
Grama revenue paripalana_margadarshini
Grama revenue paripalana_margadarshini
bansi default
Code of sales PReMA 2010
Code of sales PReMA 2010
Utai Sukviwatsirikul
Qawaa Id Al Mouslaa
Qawaa Id Al Mouslaa
Abousalimata
Ph10 pa-003
Ph10 pa-003
DARSRADAR
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNB Group
What's hot
(16)
Gram Eng Easy:9789740326366
Gram Eng Easy:9789740326366
รายงานประจำปี 2548
รายงานประจำปี 2548
Chandrayaanam
Chandrayaanam
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
Rbi banking
Rbi banking
Ph10 pa-004
Ph10 pa-004
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
Vaakkiyam amaittal 2012
Vaakkiyam amaittal 2012
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
Vro model paper
Vro model paper
Grama revenue paripalana_margadarshini
Grama revenue paripalana_margadarshini
Code of sales PReMA 2010
Code of sales PReMA 2010
Qawaa Id Al Mouslaa
Qawaa Id Al Mouslaa
Ph10 pa-003
Ph10 pa-003
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
Similar to 2012 sirisamut j health sc_evaluation of outcomes and determinants of cervical cancer screening in th_2005-9
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
Utai Sukviwatsirikul
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
DMS Library
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
Utai Sukviwatsirikul
Cough guideline 2016
Cough guideline 2016
Utai Sukviwatsirikul
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Utai Sukviwatsirikul
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Utai Sukviwatsirikul
Guideline irritable bowel syndrome 2012
Guideline irritable bowel syndrome 2012
Utai Sukviwatsirikul
คำแนะนำเกี่ยวกับโรคลำไส้แปรปรวน Ibs สำหรับแพทย์ทั่วไป (แนวทางเวชปฏิบัติ 2012)
คำแนะนำเกี่ยวกับโรคลำไส้แปรปรวน Ibs สำหรับแพทย์ทั่วไป (แนวทางเวชปฏิบัติ 2012)
Utai Sukviwatsirikul
แนวทางรักษา stroke-fast-track 2007
แนวทางรักษา stroke-fast-track 2007
Utai Sukviwatsirikul
Chocolate
Chocolate
tabrizandme
Hafezipoor
Hafezipoor
guest74b16
Ar To Eng General Sample
Ar To Eng General Sample
guest719aad
d
d
guest0b9544
7secret
7secret
paown
مقدمه ای بر داده کاوی و اکتشاف دانش
مقدمه ای بر داده کاوی و اکتشاف دانش
dataminers.ir
5s
5s
ebrahim bagheri
The President’s Speech in Cairo: A New Beginning - Dari
The President’s Speech in Cairo: A New Beginning - Dari
Obama White House
modiriatbazargani
modiriatbazargani
guesta8c13
سيكولوجيه اللغه والمرض العقلى
سيكولوجيه اللغه والمرض العقلى
mshary mshary
الکرد والحمدانیون
الکرد والحمدانیون
Chalak Muhamad
Similar to 2012 sirisamut j health sc_evaluation of outcomes and determinants of cervical cancer screening in th_2005-9
(20)
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
Cough guideline 2016
Cough guideline 2016
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Guideline irritable bowel syndrome 2012
Guideline irritable bowel syndrome 2012
คำแนะนำเกี่ยวกับโรคลำไส้แปรปรวน Ibs สำหรับแพทย์ทั่วไป (แนวทางเวชปฏิบัติ 2012)
คำแนะนำเกี่ยวกับโรคลำไส้แปรปรวน Ibs สำหรับแพทย์ทั่วไป (แนวทางเวชปฏิบัติ 2012)
แนวทางรักษา stroke-fast-track 2007
แนวทางรักษา stroke-fast-track 2007
Chocolate
Chocolate
Hafezipoor
Hafezipoor
Ar To Eng General Sample
Ar To Eng General Sample
d
d
7secret
7secret
مقدمه ای بر داده کاوی و اکتشاف دانش
مقدمه ای بر داده کاوی و اکتشاف دانش
5s
5s
The President’s Speech in Cairo: A New Beginning - Dari
The President’s Speech in Cairo: A New Beginning - Dari
modiriatbazargani
modiriatbazargani
سيكولوجيه اللغه والمرض العقلى
سيكولوجيه اللغه والمرض العقلى
الکرد والحمدانیون
الکرد والحمدانیون
More from Chuchai Sornchumni
Precision medicine
Precision medicine
Chuchai Sornchumni
Priorities with PHC (chuchai jun2018)
Priorities with PHC (chuchai jun2018)
Chuchai Sornchumni
UHC lesson learn Thailand
UHC lesson learn Thailand
Chuchai Sornchumni
ระบบประกันการดูแลระยะยาว
ระบบประกันการดูแลระยะยาว
Chuchai Sornchumni
New perspectives on global healthspending UHC
New perspectives on global healthspending UHC
Chuchai Sornchumni
2561จอร์แดนบันทึกการเดินทาง
2561จอร์แดนบันทึกการเดินทาง
Chuchai Sornchumni
Introduction2 publichealth
Introduction2 publichealth
Chuchai Sornchumni
Public finance
Public finance
Chuchai Sornchumni
DiseaseMntChrRespSyst
DiseaseMntChrRespSyst
Chuchai Sornchumni
ChronicDzMntRespiratoryIllness
ChronicDzMntRespiratoryIllness
Chuchai Sornchumni
Thailand situational assessment2015
Thailand situational assessment2015
Chuchai Sornchumni
ทบทวนประสบการณ์ Universal Health Coverage 11 ประเทศ
ทบทวนประสบการณ์ Universal Health Coverage 11 ประเทศ
Chuchai Sornchumni
Welfare analysis for uhc
Welfare analysis for uhc
Chuchai Sornchumni
พระปกเกล้า20170527
พระปกเกล้า20170527
Chuchai Sornchumni
ร่วมจ่ายทบทวนประสบการณ์ระบบสุขภาพอเมริกา
ร่วมจ่ายทบทวนประสบการณ์ระบบสุขภาพอเมริกา
Chuchai Sornchumni
นักโภชนาการนักกำหนดอาหาร2017
นักโภชนาการนักกำหนดอาหาร2017
Chuchai Sornchumni
Final annual report nhso 2559
Final annual report nhso 2559
Chuchai Sornchumni
ช่วงนี้ มีประเด็น
ช่วงนี้ มีประเด็น
Chuchai Sornchumni
สาธารณสุขเชิงรุก
สาธารณสุขเชิงรุก
Chuchai Sornchumni
Ncd nhes v_2016
Ncd nhes v_2016
Chuchai Sornchumni
More from Chuchai Sornchumni
(20)
Precision medicine
Precision medicine
Priorities with PHC (chuchai jun2018)
Priorities with PHC (chuchai jun2018)
UHC lesson learn Thailand
UHC lesson learn Thailand
ระบบประกันการดูแลระยะยาว
ระบบประกันการดูแลระยะยาว
New perspectives on global healthspending UHC
New perspectives on global healthspending UHC
2561จอร์แดนบันทึกการเดินทาง
2561จอร์แดนบันทึกการเดินทาง
Introduction2 publichealth
Introduction2 publichealth
Public finance
Public finance
DiseaseMntChrRespSyst
DiseaseMntChrRespSyst
ChronicDzMntRespiratoryIllness
ChronicDzMntRespiratoryIllness
Thailand situational assessment2015
Thailand situational assessment2015
ทบทวนประสบการณ์ Universal Health Coverage 11 ประเทศ
ทบทวนประสบการณ์ Universal Health Coverage 11 ประเทศ
Welfare analysis for uhc
Welfare analysis for uhc
พระปกเกล้า20170527
พระปกเกล้า20170527
ร่วมจ่ายทบทวนประสบการณ์ระบบสุขภาพอเมริกา
ร่วมจ่ายทบทวนประสบการณ์ระบบสุขภาพอเมริกา
นักโภชนาการนักกำหนดอาหาร2017
นักโภชนาการนักกำหนดอาหาร2017
Final annual report nhso 2559
Final annual report nhso 2559
ช่วงนี้ มีประเด็น
ช่วงนี้ มีประเด็น
สาธารณสุขเชิงรุก
สาธารณสุขเชิงรุก
Ncd nhes v_2016
Ncd nhes v_2016
Recently uploaded
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
indiancallgirl4rent
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
russian goa call girl and escorts service
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
priyashah722354
Chandigarh Escorts, 😋9988299661 😋50% off at Escort Service in Chandigarh
Chandigarh Escorts, 😋9988299661 😋50% off at Escort Service in Chandigarh
Sheetaleventcompany
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
mriyagarg453
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Sheetaleventcompany
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Sheetaleventcompany
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
indiancallgirl4rent
9316020077📞Goa Call Girls Numbers, Call Girls Whatsapp Numbers Goa
9316020077📞Goa Call Girls Numbers, Call Girls Whatsapp Numbers Goa
russian goa call girl and escorts service
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
gragmanisha42
Punjab❤️Call girls in Mohali ☎️7435815124☎️ Call Girl service in Mohali☎️ Moh...
Punjab❤️Call girls in Mohali ☎️7435815124☎️ Call Girl service in Mohali☎️ Moh...
Sheetaleventcompany
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF ...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF ...
Gfnyt.com
VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171
Call Girls Service Gurgaon
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
mriyagarg453
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
Recently uploaded
(20)
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Escorts, 😋9988299661 😋50% off at Escort Service in Chandigarh
Chandigarh Escorts, 😋9988299661 😋50% off at Escort Service in Chandigarh
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Patiala Just Call 9907093804 Top Class Call Girl Service Available
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
9316020077📞Goa Call Girls Numbers, Call Girls Whatsapp Numbers Goa
9316020077📞Goa Call Girls Numbers, Call Girls Whatsapp Numbers Goa
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Punjab❤️Call girls in Mohali ☎️7435815124☎️ Call Girl service in Mohali☎️ Moh...
Punjab❤️Call girls in Mohali ☎️7435815124☎️ Call Girl service in Mohali☎️ Moh...
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF ...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF ...
VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
2012 sirisamut j health sc_evaluation of outcomes and determinants of cervical cancer screening in th_2005-9
1.
«“√ “√«‘™“°“√ “Π“√≥
ÿ¢ ªïΣ’Ë ÚÒ ©∫—∫Σ’Ë Û æƒ…¿“§¡ - ¡‘∂ÿπ“¬π Úııı Journal of Health Science Vol. 21 No. 3 May - June 2012 Original Article π‘æπΠåμâπ©∫—∫ Π’√– »‘√‘ ¡ÿ¥* √—°¡≥’ ∫ÿμ√™π* ‡™‘≠¢«—≠ ¿ÿ™¨ß§å* À—™™“ »√’ª≈—Ë߆ π—¬π“ ª√–¥‘…∞å ‘ΣΠ‘°√* ≈’Ë≈’ Õ‘ß»√’ «à“߇ ‡πμ‘ ÿ¢ ¡∫Ÿ√≥å§ »√’‡æÁ≠ μ—π쑇« * ¬» μ’√–«—≤π“ππΣå* *‚§√ß°“√ª√–‡¡‘π‡Σ§‚π‚≈¬’·≈–π‚¬∫“¬¥â“π ÿ¢¿“æ °√–Σ√«ß “Π“√≥ ÿ¢ †Àπ૬√–∫“¥«‘Σ¬“ §≥–·æΣ¬»“ μ√å ¡À“«‘Σ¬“≈—¬ ߢ≈“π§√‘πΣ√å ‡¿“§«‘™“ ∂‘μ‘ §≥–«‘Σ¬“»“ μ√å ¡À“«‘Σ¬“≈—¬‡°…μ√»“ μ√å §¿“§«‘™“‡¿ —™°√√¡ §≥–‡¿ —™»“ μ√å ¡À“«‘Σ¬“≈—¬¡À‘¥≈ 538 °“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° ¥â«¬«‘Π’·ªª ‡¡’¬√å (Pap Smear) ·≈–«’‰Õ‡Õ (Visual Inspection with Acetic Acid) „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ∫Σ§—¥¬àÕ ¡–‡√Áߪ“°¡¥≈Ÿ°‡ªìπªí≠À“ “Π“√≥ ÿ¢Σ’Ë ”§—≠¢Õߪ√–‡Σ»‰Σ¬ Σ—ÈßΣ’Ë¡’∫√‘°“√μ√«®§—¥°√Õ߇æ◊ËÕ§âπÀ“·≈– √—°…“§«“¡º‘¥ª√°μ‘¢Õ߇´≈≈å„π√–¬–‡√‘Ë¡μâπ¡“π“π°«à“ 40 ªï ·μàÕ—μ√“°“√μ√«®§—¥°√Õß°Á¬—ßμË”¡“° μ—Èß·μàæ.». 2548 ‡ªìπμâπ¡“ √—∞∫“≈¡’π‚¬∫“¬≈¥°“√ªí≠À“¥—ß°≈à“« ‚¥¬¥”‡π‘π‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ‡Õ °“√»÷°…“π’È¡’«—μ∂ÿª√– ߧå‡æ◊ËÕª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï¢Õß‚§√ß°“√oe ·≈– ªí®®—¬Σ’ˇ°’ˬ«¢âÕß „πΣÿ°¿“§√«¡ 12 ®—ßÀ«—¥ μ—Èß·μà‡¥◊Õπ°—𬓬π 2552 ∂÷߇¥◊Õπ情¿“§¡ 2553 ´÷Ëߪ√–°Õ∫¥â«¬ 1) °“√ ”√«®ªí®®—¬¥â“πºŸâ√—∫∫√‘°“√°≈ÿࡇªÑ“À¡“¬ ®“°À≠‘ßÕ“¬ÿ 30-60 ªï ®”π«π 4,640 §π ‡°Á∫¢âÕ¡Ÿ≈¥â«¬ °“√ —¡¿“…≥å ·≈– 2) °“√ ”√«®ªí®®—¬¥â“πºŸâ„Àâ∫√‘°“√·≈–√–∫∫∫√‘°“√‚¥¬ àß·∫∫ Õ∫∂“¡Σ“߉ª√…≥’¬å ‰ª¬—ߺŸâ„Àâ∫√‘°“√Σ—ÈßÀ¡¥®”π«π 3,526 §π «‘‡§√“–Àå¢âÕ¡Ÿ≈‚¥¬«‘Π’Σ“ß ∂‘쑇™‘ßæ√√≥“·≈– ∂‘μ‘æÀÿ‚≈®‘ μ‘° ‡æ◊ËÕ«‘‡§√“–Àåªí®®—¬Σ’Ë¡’§«“¡ —¡æ—πΠå º≈°“√»÷°…“„πÀ≠‘ß°≈ÿࡺŸâ√—∫∫√‘°“√ (Õ—μ√“§«“¡√à«¡¡◊Õ 97%) æ∫Õ—μ√“°“√μ√«®§—¥°√Õß¡–‡√Áߪ“° ¡¥≈Ÿ°„π™à«ß æ.». 2548-2552 ‡Σà“°—∫√âÕ¬≈– 68 ‚¥¬‡æ‘Ë¡¢÷ÈπÕ¬à“ß™—¥‡®π„πæ.». 2551-2552 à«π„À≠àμ√«® ¥â«¬«‘Π’·ªª ‡¡’¬√å (88%) à«πΣ’Ëμ√«®¥â«¬«‘Π’«’‰Õ‡Õ (7%) §√÷ËßÀπ÷Ë߉ªμ√«®§—¥°√ÕßΣ’Ë ∂“π’Õπ“¡—¬ ªí®®—¬ à߇ √‘¡„Àâ°≈ÿࡇªÑ“À¡“¬‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õ߉¥â·°à Õ“¬ÿ√–À«à“ß 40-50 ªï Õ“»—¬„π‡¢μ™π∫Σ ª√–°Õ∫Õ“™’懰…μ√°√√¡ ‡§¬μ—Èߧ√√¿å ‰¥â√—∫¢âÕ¡Ÿ≈¢à“« “√°“√μ√«®§—¥°√Õß ¡’Σ—»π§μ‘‡™‘ß∫«°μàÕ°“√√—∫ ¢âÕ¡Ÿ≈®“° ◊ËÕ “Π“√≥–·≈–‰¥â√—∫°“√°√–μÿâπ®“° ¡“™‘°„π§√Õ∫§√—« „π¢≥–Σ’Ëªí®®—¬Σ’Ë¡’§«“¡ —¡æ—πΠå°—∫ °“√ªØ‘‡ Π°“√√—∫∫√‘°“√ ‰¥â·°à °“√‡ªìπ¡ÿ ≈‘¡ ¡’ª√–«—μ‘ Ÿ∫∫ÿÀ√’Ë §«“¡‡¢â“„®º‘¥«à“À≈—ßμ√«®·≈⫉¡àæ∫§«“¡ º‘¥ª√°μ‘°Á‰¡àμâÕß¡“μ√«®´È”Õ’° ·≈–‡¢â“„®º‘¥«à“¡’°“√„Àâ∫√‘°“√μ√«®§—¥°√Õ߇©æ“–„π‚√ß欓∫“≈‡Σà“π—Èπ
2.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ”À√—∫ºŸâ„Àâ∫√‘°“√ (Õ—μ√“μÕ∫°≈—∫ 55%) à«π„À≠à‡ÀÁπ«à“ªí≠À“¡–‡√Áߪ“°¡¥≈Ÿ°¡’§«“¡ ”§—≠·≈–°“√ μ√«®§—¥°√Õ߇ªìπ«‘Π’Σ’Ë®–™à«¬≈¥ªí≠À“π’ȉ¥â √«¡Σ—È߇ÀÁπ«à“ªí®®—¬π”‡¢â“ (‡™àπ ∫ÿ§≈“°√ °“√®—¥ √√ß∫ª√–¡“≥ ·≈–‡§√◊ËÕß¡◊Õ/Õÿª°√≥å ‡ªìπμâπ) °“√Õ∫√¡∫ÿ§≈“°√ °“√øóôπøŸ§«“¡√Ÿâ ·≈–°“√§«∫§ÿ¡§ÿ≥¿“欗߉¡à‡æ’¬ßæÕ ¢âÕ§âπæ∫¥—ß°≈à“«· ¥ß„Àâ‡ÀÁπ«à“ §«√®—¥∫√‘°“√‡™‘ß√ÿ°„πÀ≠‘ß°≈ÿà¡Σ’Ë¡’Õ—μ√“√—∫∫√‘°“√μË” ‡æ‘Ë¡«‘Π’·≈– ™àÕßΣ“ß°“√ ◊ËÕ “√„Àâ®”‡æ“–°—∫°≈ÿࡇªÑ“À¡“¬‡æ◊ËÕ à߇ √‘¡§«“¡√Ÿâ·≈–Σ—»§μ‘Σ’Ë¥’ Õ’°Σ—Èߧ«√°”Àπ¥π‚¬∫“¬Σ’Ë ™—¥‡®π‡√◊ËÕß°≈ÿà¡Õ“¬ÿ «‘Π’°“√μ√«® °“√®—¥ √√ß∫ª√–¡“≥ ·≈–‡æ‘Ë¡°“√ π—∫ πÿπªí®®—¬π”‡¢â“ ‡™à𠇧√◊ËÕß¡◊Õ Õÿª°√≥å √–∫∫∫—πΣ÷°·≈–√“¬ß“π¢âÕ¡Ÿ≈ Σ’Ë‡Õ◊ÈÕ·≈–‡ªìπ·√ß®Ÿß„®μàÕ°“√„Àâ∫√‘°“√¢ÕߺŸâªØ‘∫—μ‘ß“π §” ”§—≠: ¡–‡√Áߪ“°¡¥≈Ÿ°, °“√μ√«®§—¥°√Õß, °“√ª√–‡¡‘πº≈‚§√ß°“√ ∫Σπ” ¡–‡√Áߪ“°¡¥≈Ÿ°‡ªìπªí≠À“¥â“π “Π“√≥ ÿ¢Σ’Ë ”§—≠¢ÕßÀ≈“¬ª√–‡Σ»Σ—Ë«‚≈°(1) ª√–‡Σ»Σ’Ëæ—≤π“ ·≈â«æ∫Õÿ∫—μ‘°“√¢Õß‚√§π’ȧàÕπ¢â“ßμË” (4-11 §πμàÕ · πª√–™“°√À≠‘ß) „π¢≥–Σ’Ëª√–‡Σ»°”≈—ßæ—≤π“ ·≈–¥âÕ¬æ—≤π“æ∫Õ—μ√“Õÿ∫—μ‘°“√ Ÿß (20-55 §πμàÕ · πª√–™“°√À≠‘ß)(2) ªí®®—¬Σ’ËΣ”„À⇰‘¥§«“¡·μ°μà“ß ¥—ß°≈à“« ‰¥â·°à °“√Σ’Ëª√–‡Σ»Σ’Ëæ—≤π“·≈â«¡’‚§√ß°“√ μ√«®§—¥°√Õ߇æ◊ËÕ§âπÀ“·≈–√—°…“ºŸâªÉ«¬„π√–¬–°àÕ𠇪ìπ¡–‡√ÁßΣ’Ë¡’ª√– ‘ΣΠ‘¿“æ·≈–§«“¡§√Õ∫§≈ÿ¡°≈ÿà¡ ‡ªÑ“À¡“¬ Ÿß°«à“ª√–‡Σ»Σ’Ëæ—≤π“πâÕ¬°«à“(3) „πª√–‡Σ»‰Σ¬ ¡–‡√Áߪ“°¡¥≈Ÿ°¡’¢π“¥¢Õߪí≠À“ Õ—π¥—∫μâπ Ê ¢Õß¡–‡√ÁßΣ’Ëæ∫„π‡æ»À≠‘ß ‚¥¬ æ.». 2546 ¡’Õÿ∫—μ‘°“√‡Σà“°—∫ 18.1 μàÕ· πª√–™“°√À≠‘ß ´÷Ëß„πªï ‡¥’¬«°—πæ∫®”π«πºŸâªÉ«¬√“¬„À¡àª√–¡“≥ 6,300 √“¬(4) °√–Σ√«ß “Π“√≥ ÿ¢„Àâ∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å (Pap smear) ¡“°«à“ 40 ªï μàÕ¡“„π æ.».2543 ‡√‘Ë¡„Àâ∫√‘°“√μ√«®¥â«¬«‘Π’«’‰Õ‡Õ (Visual inspection with Acetic Acid, VIA) º≈®“° °“√¥”‡π‘πß“πΣ’Ëºà“π¡“æ∫«à“§«“¡§√Õ∫§≈ÿ¡°“√‡¢â“ √—∫∫√‘°“√À≠‘ß°≈ÿࡇªÑ“À¡“¬¬—߉¡à‡ªìπ‰ªμ“¡ ‡ªÑ“ª√– ߧåΣ’Ë°”Àπ¥‰«â ¥—ßπ—Èπ„π æ.».2548 ®÷߇√‘Ë¡ ¥”‡π‘π‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥ ¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ ‡ªìπ‚§√ß°“√√–¬– 5 ªï ‚¥¬¡’«—μ∂ÿª√– ߧå‡æ◊ËÕ„Àâª√–™“™π¡’§«“¡√Ÿâ‡√◊ËÕß¡–‡√Áß «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û ª“°¡¥≈Ÿ°·≈–„À⧫“¡ ”§—≠°—∫°“√μ√«®§—¥°√Õß „Àâ ∫√‘°“√μ√«®§—¥°√Õ߇æ◊ËÕ§âπÀ“§«“¡º‘¥ª√°μ‘¢Õ߇´≈≈å ¡–‡√Áß„π√–¬–‡√‘Ë¡μâπæ√âÕ¡Σ—Èß π—∫ πÿπ√–∫∫ àßμàÕ «‘π‘®©—¬·≈–√—°…“‚√§¡–‡√Áߪ“°¡¥≈Ÿ°Õ¬à“ß¡’ª√– ‘ΣΠ‘- ¿“æ ·°àÀ≠‘ß°≈ÿࡇªÑ“À¡“¬„Àâ§√Õ∫§≈ÿ¡Σÿ°æ◊ÈπΣ’Ë‚¥¬ À≠‘ß‰Σ¬Σ’Ë¡’Õ“¬ÿ 35 40 45 50 55 ·≈– 60 ªï „À≥â √—∫∫√‘°“√μ√«®§—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å„πΣÿ°®—ßÀ«—¥ Σ—Ë«ª√–‡Σ» πÕ°®“°π’È ∂“π欓∫“≈„π 15 ®—ßÀ«—¥Σ’Ë æ√âÕ¡·≈– ¡—§√„®„Àâ∫√‘°“√¥â«¬«‘Π’«’‰Õ‡Õ§«∫§Ÿà°—∫«‘Π’ ·ªª ‡¡’¬√å ‚¥¬„™â«‘Π’«’‰Õ‡Õ°—∫ºŸâΣ’Ë¡’Õ“¬ÿ 30-44 ªï (¬°‡«âπÀ≠‘ßÕ“¬ÿ 35 ·≈– 40 ªï) ·≈–„™â«‘Π’·ªª ‡¡’¬√å °—∫ºŸâΣ’Ë¡’Õ“¬ÿ 35 40 45 50 55 ·≈– 60 ªï Σ—Èßπ’È°√¡ °“√·æΣ¬å·≈–°√¡Õπ“¡—¬√—∫º‘¥™Õ∫√–∫∫°“√μ√«® §—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å·≈– «‘Π’«’‰Õ‡Õμ“¡≈”¥—∫ ‚¥¬ §√Õ∫§≈ÿ¡Σ—Èߥâ“π«‘™“°“√ °“√¥”‡π‘πß“π ·≈–√–∫∫ ¢âÕ¡Ÿ≈ “√ π‡Σ»(5) ¡’√“¬ß“πº≈°“√¥”‡π‘πß“π„π™à«ß æ.». 2550 ·√°æ∫Õ—μ√“°“√μ√«®§—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å §√Õ∫§≈ÿ¡°≈ÿࡇªÑ“À¡“¬¢Õß‚§√ß°“√ª√–¡“≥√âÕ¬≈– 50(6) Õ¬à“߉√°Áμ“¡®“°∞“π¢âÕ¡Ÿ≈Σ–‡∫’¬π§—¥°√Õß Pap Registry ´÷Ë߇°Á∫Σ–‡∫’¬π§—¥°√Õß«‘Π’·ªª ‡¡’¬√å·≈– CPIStm ´÷Ë߇°Á∫Σ–‡∫’¬π§—¥°√Õß«‘Π’«’‰Õ‡Õ‚¥¬§”π«≥ ®“°∞“πª√–™“°√À≠‘ß°≈ÿࡇªÑ“À¡“¬Σ—Ë«ª√–‡Σ» æ∫ Õ—μ√“§√Õ∫§≈ÿ¡Σ’ËμË”°«à“¡“° °≈à“«§◊Õ «‘Π’·ªª ‡¡’¬√å √âÕ¬≈– 8.8 ·≈–«‘Π’«’‰Õ‡Õ√âÕ¬≈– 18.8(7) ıÛ˘
3.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 Õ—μ√“°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°Õ“®‡°‘¥ ®“°À≈“¬ªí®®—¬Σ—ÈßΣ’Ë‡°’ˬ«°—∫À≠‘ß°≈ÿࡇªÑ“À¡“¬Σ’ˇªìπ ºŸâ√—∫∫√‘°“√ ºŸâ„Àâ∫√‘°“√ √–∫∫∫√‘°“√ ·≈–√–∫∫ π—∫ πÿπ ¥—ßπ—Èπ°“√»÷°…“π’È ®÷ß¡’«—μ∂ÿª√– ߧå‡æ◊ËÕª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°- ¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ‡Õ ‡æ◊ËÕπ” ¢âÕ¡Ÿ≈ª√–°Õ∫„π°“√æ‘®“√≥“ª√—∫°≈¬ÿΣΠå·≈–«‘Π’°“√ ªØ‘∫—μ‘ß“π„Àâ¡’§«“¡‡À¡“– ¡ ´÷Ëß®–™à«¬„Àâ∫√√≈ÿ‡ªÑ“- À¡“¬¢Õß°“√ªÑÕß°—π·≈–§«∫§ÿ¡¡–‡√Áߪ“°¡¥≈Ÿ°μàÕ‰ª «‘Π’°“√»÷°…“ °“√»÷°…“π’ȇªìπ°“√«‘®—¬‡™‘ß ”√«® ¥”‡π‘π°“√μ—Èß ·μà‡¥◊Õπ°—𬓬π æ.».2552 ∂÷߇¥◊Õπ情¿“§¡ æ.». 2553 ·∫àßÕÕ°‡ªìπ 2 à«π ‰¥â·°à °“√»÷°…“„π°≈ÿà¡ ºŸâ√—∫∫√‘°“√ ·≈–°“√»÷°…“„π°≈ÿࡺŸâ„Àâ∫√‘°“√ ´÷Ëß¡’ «—μ∂ÿª√– ߧ凩擖 ¥—ßπ’È 1. ‡æ◊ËÕª√–‡¡‘πÕ—μ√“°“√μ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ° ·≈–»÷°…“ªí®®—¬®“°°≈ÿࡺŸâ√—∫∫√‘°“√ Σ’Ë¡’º≈ μàÕ°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√ÕߢÕߺŸâÀ≠‘ß°≈ÿࡇªÑ“- À¡“¬Õ“¬ÿ 30-60 ªï 2. ‡æ◊ËÕ»÷°…“ªí®®—¬¥â“πºŸâ„Àâ∫√‘°“√ ºŸâ∫√‘À“√ √–∫∫∫√‘°“√·≈–√–∫∫ π—∫ πÿπÕ◊Ëπ Ê Σ’Ë¡’º≈μàÕ°“√ ‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¢ÕßÀ≠‘ß °≈ÿࡇªÑ“À¡“¬ æ◊ÈπΣ’Ë»÷°…“: √«¡ 12 ®—ßÀ«—¥ ‰¥â·°à ®—ßÀ«—¥‡™’¬ß„À¡à ·æ√à æ‘…≥ÿ‚≈° π§√æπ¡ √âÕ¬‡ÕÁ¥ π§√√“™ ’¡“ √–·°â« π§√ª∞¡ ‡æ™√∫ÿ√’ ™ÿ¡æ√ ߢ≈“ ·≈–π§√»√’Π√√¡√“™ ¡’·π«Σ“߇≈◊Õ°®—ßÀ«—¥μ—«Õ¬à“ߥ⫬°“√ ÿà¡Õ¬à“߇ªìπ √–∫∫„π 4 ™—Èπ¿Ÿ¡‘ (stratified four-stage sampling) ‚¥¬·∫àßæ◊ÈπΣ’Ëª√–‡Σ»‰Σ¬‡ªìπ 4 ¿“§ ‰¥â·°à ¿“§‡Àπ◊Õ ¿“§μ–«—πÕÕ°‡©’¬ß‡Àπ◊Õ ¿“§°≈“ß/μ–«—πÕÕ°/μ–«—πμ° ·≈–¿“§„μâ ·≈–·∫àß®—ßÀ«—¥„π·μà≈–¿“§‡ªìπ 3 °≈ÿà¡ μ“¡≈—°…≥–æ◊ÈπΣ’Ë‡ªìπ¢π“¥„À≠à °≈“ß·≈–¢π“¥‡≈Á° ·≈– ÿࡇ≈◊Õ°μ“¡≈—°…≥–æ◊ÈπΣ’Ë§≈–°—π¿“§≈– 3 ®—ßÀ«—¥ ‚¥¬·μà≈–¿“§®– ÿà¡®—ßÀ«—¥Õ¬à“ßßà“¬ (simple random sampling, SRS) Σ’Ë¡’°“√μ√«®§—¥°√ÕßΣ—Èß 2 «‘Π’§◊Õ «’‰Õ‡Õ°—∫«‘Π’·ªª ‡¡’¬√å¡“ 1 ®—ßÀ«—¥ ·≈– ÿà¡®—ßÀ«—¥ Õ¬à“ßßà“¬ (SRS) Σ’Ëμ√«®§—¥°√Õ߇©æ“–«‘Π’·ªª ‡¡’¬√å¡“ 2 ®—ßÀ«—¥ à«πΣ’Ë 1 °“√»÷°…“„π°≈ÿࡺŸâ√—∫∫√‘°“√ 1) √Ÿª·∫∫°“√»÷°…“ ‡ªìπ°“√ ”√«®¿“§μ—¥¢«“ß (cross-sectional survey) 2) ª√–™“°√·≈–°≈ÿà¡μ—«Õ¬à“ß ª√–™“°√ §◊Õ ºŸâÀ≠‘ß‰Σ¬Õ“¬ÿ 30-60 ªï ´÷Ë߇ªìπ°≈ÿࡇªÑ“À¡“¬ ‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’ ·ªª ‡¡’¬√å·≈–«’‰Õ æ.». 2548 - 2552 °≈ÿà¡μ—«Õ¬à“ß §◊Õ ºŸâÀ≠‘ß‰Σ¬Õ“¬ÿ 30-60 ªïΣ’Ë¡’√“¬™◊ËÕ„πΣ–‡∫’¬π°“√ μ√«®§—¥°√ÕߢÕß ∂“π欓∫“≈„πæ◊ÈπΣ’Ë»÷°…“„πæ.». 2548 - 2552 3) ¢π“¥μ—«Õ¬à“ß·≈–°“√ ÿà¡μ—«Õ¬à“ß °“√§”π«≥ ¢π“¥μ—«Õ¬à“ß„™â Ÿμ√ ‚¥¬Σ’Ë 1.96 (§à“§ßΣ’ËΣ’Ë√–¥—∫§«“¡‡™◊ËÕ¡—Ëπ 95%) N = ®”π«πª√–™“°√ºŸâÀ≠‘߇ªÑ“À¡“¬Õ“¬ÿ 30- 60 ªïΣ—Ë«ª√–‡Σ» σ = §à“§«“¡·ª√ª√«π¢Õß°“√ ª√–¡“≥§à“ª√–™“°√ ´÷ËßΣ’Ëºà“π¡“‰¡à¡’°“√»÷°…“Σ’Ë “¡“√∂√–∫ÿ‰¥â«à“®”π«πÀ≠‘ß°≈ÿࡇªÑ“À¡“¬Õ“¬ÿ 30-60 ªï„π√–¥—∫¿“§À√◊Õª√–‡Σ»π—Èπ¡’§«“¡·ª√ª√«π¡“° πâÕ¬‡æ’¬ß„¥ °“√»÷°…“§√—Èßπ’È®÷ß°”Àπ¥„Àâ‡Σà“°—∫ 1 ·≈– ε = §«“¡º‘¥æ≈“¥À√◊Õ§«“¡§≈“¥‡§≈◊ËÕπΣ’Ë¬Õ¡„À⇰‘¥¢÷È𠉥â„πß“π«‘®—¬ ‡Σà“°—∫√âÕ¬≈– 4 ‚¥¬°”Àπ¥Õ—μ√“°“√ °“√‰¡à¬‘π¥’„Àâ¢âÕ¡Ÿ≈‡Σà“°—∫√âÕ¬≈– 20 ‰¥â¢π“¥μ—«Õ¬à“ß Σ—Èß ‘ÈπΣ—Èß ‘Èπ 4,640 §π „π™—Èπ¿Ÿ¡‘Σ’Ë 3 ÿࡇ≈◊Õ°μ“¡ —¥ à«π®”π«π™ÿ¡™πÀ√◊ÕÀ¡Ÿà∫â“π„πÕ”‡¿Õμ—«Õ¬à“ßπ—Èπ Ê (probability proportional to size) ‰¥â®”π«π À¡Ÿà∫â“πÀ√◊Õ™ÿ¡™πΣ—Èß ‘Èπ 232 ·À≈àß „π™—Èπ¿Ÿ¡‘ ÿ¥Σ⓬ ÿࡇ≈◊Õ°°≈ÿà¡μ—«Õ¬à“ß„πæ◊ÈπΣ’ËÕ¬à“߇ªìπ√–∫∫ À¡Ÿà∫â“π À√◊Õ™ÿ¡™π≈– 20 §π¥â«¬μ“√“ß ÿà¡®“°Σ–‡∫’¬π°≈ÿà¡ 540 Journal of Health Science 2012 Vol. 21 No. 3
4.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ‡ªÑ“À¡“¬μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¢Õß ∂“π 欓∫“≈Σ’Ë√—∫º‘¥™Õ∫ 4) ‡§√◊ËÕß¡◊Õ‡°Á∫¢âÕ¡Ÿ≈ ºŸâ«‘®—¬æ—≤π“·∫∫ —¡¿“…≥å(8) ‡æ◊ËÕ‡°Á∫¢âÕ¡Ÿ≈¥—ßπ’È 1) ≈—°…≥–¢âÕ¡Ÿ≈Σ—Ë«‰ª ‰¥â·°à ¢âÕ¡Ÿ≈≈—°…≥–ª√–™“°√ ¢âÕ¡Ÿ≈ ∂“𖇻√…∞°‘® ·≈– —ߧ¡ 2) ¢âÕ¡Ÿ≈¥â“πæƒμ‘°√√¡ ÿ¢¿“æ 3) °“√‰¥â √—∫¢à“« “√‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥ °√Õß 4) §«“¡√Ÿâ‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«® §—¥°√Õß 5) Σ—»π§μ‘‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√ μ√«®§—¥°√Õß 6) ª√–«—μ‘°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥ °√Õß„π√Õ∫ 5 ªïΣ’Ëºà“π¡“ 5) «‘Π’‡°Á∫¢âÕ¡Ÿ≈ ‡ªìπ°“√ —¡¿“…≥åμ—«μàÕμ—«°—∫ °≈ÿà¡μ—«Õ¬à“ß ‚¥¬‡™‘≠°≈ÿà¡μ—«Õ¬à“ßμ“¡√“¬™◊ËÕ ÿà¡¡“ ª√–™ÿ¡„π ∂“πΣ’Ë„°≈â∫â“𠇙àπ ∂“π’Õπ“¡—¬ »“≈“ °≈“ß∫â“π «—¥ ‚√߇√’¬π ‡ªìπμâπ π—°«‘®—¬Õà“π¢âÕ§”∂“¡ „Àâ°≈ÿà¡μ—«Õ¬à“ßøíß·≈–∫—πΣ÷°§”μÕ∫≈ß„π·∫∫ —¡¿“…≥å πÕ°®“°π’Èπ—°«‘®—¬‰¥â ÿà¡√“¬™◊ËÕ®“°Σ–‡∫’¬π°≈ÿࡇªÑ“- À¡“¬‡ªìπ 2 ∫—≠™’ À“° —¡¿“…≥å°≈ÿà¡μ—«Õ¬à“߉¡à§√∫ 20 §π „π∫—≠™’Σ’Ë 1 ‚¥¬æ‘®“√≥“°≈ÿà¡Õ“¬ÿΣ’Ë¢“¥À“¬‰ª„π ·μà≈–æ◊ÈπΣ’Ë ·≈–À“°‰¥â®”π«π°≈ÿà¡μ—«Õ¬à“߉¡à§√∫„π ∫—≠™’Σ’Ë 2 °Á∂◊Õ«à“‡ªìπÕ—π ‘Èπ ÿ¥ 6) °“√«‘‡§√“–Àå¢âÕ¡Ÿ≈ «‘‡§√“–Àå¢âÕ¡Ÿ≈¥â«¬ ‚ª√·°√¡ ”‡√Á®√Ÿª ¡’ ∂‘μ‘Σ’Ë„™â ¥—ßπ’È 1. ∂‘쑇™‘ßæ√√≥“ ‰¥â·°à §à“§«“¡∂’Ë √âÕ¬≈– —¥ à«π §à“‡©≈’ˬ·≈– à«π‡∫’ˬ߇∫π¡“μ√∞“π‡æ◊ËÕ ∫√√¬“¬≈—°…≥–Σ—Ë«‰ª ‡™àπ ¢âÕ¡Ÿ≈≈—°…≥–ª√–™“°√ ¢âÕ¡Ÿ≈ ∂“𖇻√…∞°‘®·≈– —ߧ¡ æƒμ‘°√√¡ ÿ¢¿“æ §«“¡√Ÿâ·≈–Σ—»π§μ‘‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√ √—∫∫√‘°“√μ√«®§—¥°√ÕߢÕßÀ≠‘ßμ—«Õ¬à“ß 2. ∂‘쑇™‘ß«‘‡§√“–Àå ‰¥â·°à ∂‘쑧«“¡∂¥∂Õ¬ ‚≈®‘ μ‘°‡™‘ßæÀÿ ‡æ◊ËÕæ‘ Ÿ®π姫“¡ —¡æ—πΠå¢Õßªí®®—¬μà“ßÊ μàÕ°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√ÕߢÕßÀ≠‘ßμ—«Õ¬à“ß ‰¥â §à“ adjusted odds ratio (ORadj) ·≈–™à«ß§«“¡‡™◊ËÕ ¡—ËπΣ’Ë 95% (95% confidence interval) ‚¥¬°”Àπ¥ √–¥—∫π—¬ ”§—≠Σ“ß ∂‘μ‘Σ’Ë 0.05 (p-value ≤ 0.05) «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û 3. ª√–¡“≥§à“¬Õ¥√«¡ª√–™“°√ ‡ªìπ°“√ §”π«≥§à“∂à«ßπÈ”Àπ—°‡æ◊ËÕª√–¡“≥°“√‡¢â“√—∫∫√‘°“√ μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°®“°°“√ ”√«®„πÀ≠‘ß μ—«Õ¬à“߇ªìπÀ≠‘ߪ√–™“°√°≈ÿࡇªÑ“À¡“¬√–¥—∫ª√–‡Σ» à«πΣ’Ë 2 °“√»÷°…“„π°≈ÿࡺŸâ„Àâ∫√‘°“√ 1) √Ÿª·∫∫°“√»÷°…“ ‡ªìπ°“√ ”√«®¿“§μ—¥¢«“ß (cross-sectional survey) 2) ª√–™“°√·≈–°≈ÿà¡μ—«Õ¬à“ß ª√–™“°√ §◊Õ ºŸâ- „Àâ∫√‘°“√ ‰¥â·°à ºŸâ∫√‘À“√·≈–ºŸâªØ‘∫—μ‘ß“πΣ’Ë‡°’ˬ«¢âÕß °—∫°“√§«∫§ÿ¡ ªÑÕß°—π¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«® §—¥°√Õß®“° ∂“π∫√‘°“√ ÿ¢¿“æ —ß°—¥°√–Σ√«ß “Π“√≥ ÿ¢ ‰¥â·°à ”π—°ß“π “Π“√≥ ÿ¢®—ßÀ«—¥ ( ®.) ”π—°ß“π “Π“√≥ ÿ¢Õ”‡¿Õ ( Õ.) ‚√ß欓∫“≈ (√æ.) ·≈– ∂“π’Õπ“¡—¬À√◊Õ‚√ß欓∫“≈ à߇ √‘¡ ÿ¢¿“æμ”∫≈ (√æ. μ.) „πæ◊ÈπΣ’Ë»÷°…“Σ—Èß 12 ®—ßÀ«—¥ ‚¥¬°≈ÿà¡ μ—«Õ¬à“ߧ√—Èßπ’È §◊Õ ºŸâ∫√‘À“√·≈–ºŸâªØ‘∫—μ‘ß“πΣ—ÈßÀ¡¥„π ∂“π∫√‘°“√ ÿ¢¿“楗߰≈à“« 3) ¢π“¥μ—«Õ¬à“ß·≈–°“√‡≈◊Õ°μ—«Õ¬à“ß π—°«‘®—¬ ‡≈◊Õ°μ—«Õ¬à“ß·∫∫‡®“–®ß ‚¥¬‡≈◊Õ°ºŸâ„Àâ∫√‘°“√®“° ®. Õ. √æ. ·≈–√æ. μ. Σ—ÈßÀ¡¥®”π«π 3,526 §π (ºŸâªØ‘∫—μ‘ß“π 2,827 §π·≈–ºŸâ∫√‘À“√ 699 §π) ‚¥¬ ºŸâ∫√‘À“√‡ªìπºŸâΣ’ËΣ”Àπâ“Σ’Ë¥â“π°“√∫√‘À“√ ‡™àπ 𓬠·æΣ¬å “Π“√≥ ÿ¢®—ßÀ«—¥ “Π“√≥ ÿ¢Õ”‡¿Õ ºŸâÕ”π«¬ °“√À√◊Õ√ÕߺŸâÕ”π«¬°“√„π‚√ß欓∫“≈ √«¡∂÷ßÀ—«Àπâ“ °≈ÿà¡ß“π„π·ºπ° Ÿμ‘π√’‡«™ ‡«™°√√¡ —ߧ¡À√◊Õ‡«™- ªØ‘∫—쑧√Õ∫§√—«·≈–™ÿ¡™π ß“π à߇ √‘¡ ÿ¢¿“æ·≈– ªÑÕß°—π‚√§ Σˇ’°Ë’¬«¢âÕß°—∫°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°- ¡¥≈Ÿ° à«πºŸâªØ‘∫—μ‘ß“π‡ªìπºŸâΣ’ËΣ”ß“π‡°’Ë¬«¢âÕß°—∫°“√ §«∫§ÿ¡·≈–ªÑÕß°—π¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«® §—¥°√Õß ‡™àπ °≈ÿà¡ß“π§«∫§ÿ¡‚√§‰¡àμ‘¥μàÕ °≈ÿà¡ß“π à߇ √‘¡ ÿ¢¿“æ ΩÉ“¬‡«™°√√¡ —ߧ¡À√◊ÕΩÉ“¬‡«™ªØ‘∫—μ‘ §√Õ∫§√—«·≈–™ÿ¡™π ‡®â“Àπâ“Σ’Ë√æ. μ. ‡ªìπμâπ 4) ‡§√◊ËÕß¡◊Õ‡°Á∫¢âÕ¡Ÿ≈ ºŸâ«‘®—¬æ—≤π“·∫∫ Õ∫∂“¡(8) ®”π«π 2 ™ÿ¥ ™ÿ¥Σ’Ë 1 ·∫∫ Õ∫∂“¡ ”À√—∫ ºŸâ∫√‘À“√ ª√–°Õ∫¥â«¬§”∂“¡ 3 ¥â“π ‰¥â·°à 1) ¢âÕ¡Ÿ≈ ıÙÒ
5.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 Σ—Ë«‰ª·≈–°“√ªØ‘∫—μ‘ß“π 2) §«“¡§‘¥‡ÀÁπμàÕπ‚¬∫“¬ ·≈–°“√„Àâ∫√‘°“√μ√«®§—¥°√Õß 3) ªí≠À“·≈–Õÿª √√§ ™ÿ¥Σ’Ë 2 ‡ªìπ·∫∫ Õ∫∂“¡ ”À√—∫ºŸâªØ‘∫—μ‘ß“π‚¥¬‡æ‘Ë¡ ‡μ‘¡„π 3 ¥â“π‰¥â·°à 4) ª√–«—μ‘°“√‡¢â“√—∫°“√Õ∫√¡ 5) §«“¡√Ÿâ‡°’ˬ«°—∫°“√μ√«®§—¥°√Õß 6) ¢âÕ¡Ÿ≈°“√„Àâ ∫√‘°“√μ√«®§—¥°√ÕߢÕß ∂“π欓∫“≈·≈– 7) §«“¡ ‡ÀÁπμàÕ°“√‡¢â“√—∫∫√‘°“√¢ÕßÀ≠‘ß°≈ÿࡇªÑ“À¡“¬ 5) «‘Π’‡°Á∫¢âÕ¡Ÿ≈ π—°«‘®—¬ àß·∫∫ Õ∫∂“¡‰ª¬—ß°≈ÿà¡ μ—«Õ¬à“ßΣ“ß‰ª√…≥’¬å‚¥¬·π∫´Õß®¥À¡“¬ √“¬ ≈–‡Õ’¬¥·≈–Σ’ËÕ¬Ÿà‡æ◊ËÕ àß°≈—∫ πÕ°®“°π—Èππ—°«‘®—¬‰¥â ª√– “πß“π√à«¡°—∫‡®â“Àπâ“Σ’ËΩÉ“¬§«∫§ÿ¡‚√§‰¡àμ‘¥μàÕ ¢Õß ”π—°ß“π “Π“√≥ ÿ¢®—ßÀ«—¥‡æ◊ËÕμ‘¥μ“¡°“√ àß ·∫∫ Õ∫∂“¡Σ“ß®¥À¡“¬À√◊Õ‡ªìπºŸâ√«∫√«¡ ·∫∫ Õ∫∂“¡·≈â« àß¡“„Àâπ—°«‘®—¬Õ’°§√—Èß 6) °“√«‘‡§√“–Àå¢âÕ¡Ÿ≈ 1. „™â ∂‘쑇™‘ßæ√√≥“ ‰¥â·°à §à“§«“¡∂’Ë √âÕ¬≈– —¥ à«π §à“‡©≈’ˬ·≈– à«π‡∫’ˬ߇∫π¡“μ√∞“π‡æ◊ËÕ ÕΠ‘∫“¬≈—°…≥–Σ—Ë«‰ª √«¡Σ—ÈßÕΠ‘∫“¬§«“¡√Ÿâ §«“¡ ‡¢â“„®·≈–§«“¡§‘¥‡ÀÁπμàÕ√–∫∫°“√„Àâ∫√‘°“√/π‚¬∫“¬ 2. «‘‡§√“–Àå¢âÕ¡Ÿ≈¥â“πªí≠À“/Õÿª √√§·≈–¢âÕ ‡ πÕ·π–„π°“√„Àâ∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° „™â°“√®—¥À¡«¥À¡Ÿà·≈–«‘‡§√“–Àå‡æ◊ËÕ √ÿª‡π◊ÈÕÀ“ °“√μ√«® Õ∫‡§√◊ËÕß¡◊Õ ·∫∫ —¡¿“…≥åÀ≠‘ß°≈ÿࡇªÑ“À¡“¬·≈–·∫∫ Õ∫∂“¡ºŸâ„Àâ∫√‘°“√‰¥âºà“π°“√μ√«® Õ∫§«“¡μ√߇™‘ß ‡π◊ÈÕÀ“‚¥¬ºŸâΣ√ߧÿ≥«ÿ≤‘®”π«π 5 §π (‚§√ß°“√ ª√–‡¡‘π‡Σ§‚π‚≈¬’·≈–π‚¬∫“¬¥â“π ÿ¢¿“æ 2 §π ∂“∫—π¡–‡√Áß·Ààß™“μ‘ °√¡°“√·æΣ¬å 1 §π ·≈–°√¡ Õπ“¡—¬ 2 §π) ·≈–Σ¥ Õ∫°—∫°≈ÿࡇªÑ“À¡“¬®”π«π 60 §πΣ’ËÕ¬ŸàπÕ°æ◊ÈπΣ’Ëμ—«Õ¬à“ß ¥â«¬°“√ —¡¿“…≥åμàÕμ—«μàÕ °—∫°≈ÿࡇªÑ“À¡“¬ Σ¥ Õ∫¢âÕ§”∂“¡‡√◊ËÕߧ«“¡√Ÿâ·≈– Σ—»π§μ‘‚¥¬æ‘®“√≥“¢âÕ§”∂“¡Σ’Ë¡’Õ”π“®®”·π°¡“° °«à“ 1.75 À≈—ß®“°π—ÈπΣ¥ Õ∫§«“¡πà“‡™◊ËÕ∂◊Õ‚¥¬„™â —¡ª√– ‘ΣΠ‘Ï·Õ≈ø“¢Õߧ√Õπ∫“§ „π¢âÕ§”∂“¡‡√◊ËÕß §«“¡√Ÿâ·≈–Σ—»π§μ‘‡À≈à“π—È𠉥â‡Σà“°—∫ 0.82 ·≈– 0.89 à«π·∫∫ Õ∫∂“¡ ”À√—∫ºŸâ„Àâ∫√‘°“√π—Èπ‰¥â𔉪 Σ¥ Õ∫°—∫ºŸâªØ‘∫—μ‘ß“π·≈–ºŸâ∫√‘À“√®”π«π 20 §πΣ’Ë Õ¬ŸàπÕ°æ◊ÈπΣ’Ëμ—«Õ¬à“ß ‚¥¬¢Õ„Àâ°√Õ°¢âÕ¡Ÿ≈·≈– Õ∫∂“¡§«“¡‡¢â“„® §«“¡¬“°ßà“¬·≈–§«“¡ §√Õ∫§≈ÿ¡¢Õ߇π◊ÈÕÀ“‡æ‘Ë¡‡μ‘¡ æ‘®“√≥“‡≈◊Õ°¢âÕ§”∂“¡ ª√—∫ª√ÿß ·°â‰¢¥â«¬°“√ª√–™ÿ¡¢Õ§«“¡§‘¥‡ÀÁπ®“° ºŸâ‡™’ˬ«™“≠·≈–ºŸâΣ√ߧÿ≥«ÿ≤‘ °“√§«∫§ÿ¡§ÿ≥¿“æß“π«‘®—¬ ¡’°“√§«∫§ÿ¡§ÿ≥¿“æ°“√‡°Á∫¢âÕ¡Ÿ≈¢Õßπ—°«‘®—¬ ®“° ºŸâ‡™’ˬ«™“≠·≈–Σ’Ëª√÷°…“‚§√ß°“√«‘®—¬„π√–¥—∫æ◊ÈπΣ’Ë πÕ°®“°π—Èπ‰¥âπ”‡¢â“·≈–μ√«® Õ∫¢âÕ¡Ÿ≈„™â‚ª√·°√¡ §Õ¡æ‘«‡μÕ√å OMERET(9) ‡æ◊ËÕ≈¥§«“¡º‘¥æ≈“¥Σ’ˇ°‘¥ ®“°¡πÿ…¬å √«¡Σ—Èß¡’°“√𔇠πÕ§«“¡°â“«Àπâ“·≈– ª√÷°…“ºŸâ‡™’ˬ«™“≠®”π«π 2 §√—Èß °“√æ‘Σ—°…å ‘ΣΠ‘ºŸâ„Àâ¢âÕ¡Ÿ≈ ºŸâ«‘®—¬·≈–Σ’¡‡°Á∫¢âÕ¡Ÿ≈·®âß√“¬≈–‡Õ’¬¥‚§√ß°“√ ·≈–«—μ∂ÿª√– ߧåß“π«‘®—¬ √«¡Σ—Èߺ≈ª√–‚¬™πåΣ’Ë‰¥â√—∫ ®“°°“√„Àâ¢âÕ¡Ÿ≈·°àÀ≠‘ßμ—«Õ¬à“ß·≈– à«π√«¡ ´÷ËßÀ≈—ß Σ√“∫¢âÕ¡Ÿ≈·≈â«®–≈ß≈“¬¡◊Õ™◊ËÕ„Àâ¢âÕ¡Ÿ≈¥â«¬§«“¡ ‡μÁ¡„®°àÕπ°“√ —¡¿“…≥å·≈–À“°‰¡àÕ¬“°μÕ∫§”∂“¡ À√◊Õ¢Õ¬ÿμ‘√–À«à“ß°“√„Àâ —¡¿“…≥å°Á “¡“√∂Σ”‰¥â·≈– ‰¡à¡’º≈‡ ’¬„¥ Ê Σ—Èß ‘Èπ Õ’°Σ—ÈߢâÕ¡Ÿ≈Σ’Ë‰¥â®–ªî¥‡ªì𠧫“¡≈—∫‰¡à‡º¬·æ√à‡ªìπ√“¬∫ÿ§§≈ ·≈–·∫∫ —¡¿“…≥å ‡À≈à“π—Èπ®–∂Ÿ°Σ”≈“¬‡¡◊ËÕæâπ√–¬– 5 ªï º≈°“√»÷°…“ º≈°“√»÷°…“·∫àßÕÕ°‡ªìπ 3 à«π‰¥â·°à à«πΣ’Ë 1 ≈—°…≥–¢ÕߺŸâ„Àâ¢âÕ¡Ÿ≈„π°≈ÿࡺŸâ√—∫∫√‘°“√ ‰¥â·°à ¢âÕ¡Ÿ≈≈—°…≥–ª√–™“°√ ¢âÕ¡Ÿ≈ ∂“𖇻√…∞°‘® ·≈– —ߧ¡ ·≈–≈—°…≥–¢âÕ¡Ÿ≈Σ—Ë«‰ª·≈–°“√ªØ‘∫—μ‘ß“π ¢ÕߺŸâ„Àâ∫√‘°“√ à«πΣ’Ë 2 º≈ —¡ƒΣΠ‘Ï¢Õß°“√¥”‡π‘πß“π‚§√ß°“√ 542 Journal of Health Science 2012 Vol. 21 No. 3
6.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 §—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å ·≈–«’‰Õ æ.». 2548 - æ.». 2552 à«πΣ’Ë 3 ªí®®—¬Σ’ˇ°’ˬ«¢âÕßμàÕº≈ —¡ƒΣΠ‘Ï¢Õß°“√ ¥”‡π‘π‚§√ß°“√oe ·∫à߇ªìπªí®®—¬¥â“πºŸâ√—∫∫√‘°“√·≈– ªí®®—¬¥â“πºŸâ„Àâ∫√‘°“√ 1. ≈—°…≥–¢ÕߺŸâ„Àâ¢âÕ¡Ÿ≈„π°≈ÿࡺŸâ√—∫∫√‘°“√ ºŸâ√—∫∫√‘°“√μÕ∫§”∂“¡ —¡¿“…≥凪ìπ®”π«πΣ—Èß ‘Èπ 4,512 §π (Õ—μ√“„À⧫“¡√à«¡¡◊Õ 97%) à«π„À≠àæ—° Õ“»—¬„πæ◊ÈπΣ’Ë„°≈âÀ√◊ÕÀà“ß®“°Õ”‡¿Õ‡¡◊Õߪ“π°≈“ß (ª√–¡“≥ 10-40 °‘‚≈‡¡μ√) (43%) ¡’Õ“¬ÿ‡©≈’ˬ 46 ªï à«π„À≠à¡’Õ“¬ÿ√–À«à“ß 40-49 ªï (40%) ¡’ ∂“π¿“æ §Ÿà·≈–Õ¬Ÿà√à«¡°—π°—∫§Ÿà ¡√ (80%) ‡°◊Õ∫Σ—ÈßÀ¡¥π—∫∂◊Õ »“ π“æÿΣΠ (95%) à«π„À≠à®∫°“√»÷°…“„π√–¥—∫ ª√–∂¡»÷°…“ (72%) ª√–°Õ∫Õ“™’懰…μ√°√√¡ (41%) √“¬‰¥âμàÕ‡¥◊Õπ¡’§à“°≈“ßÀ√◊Õ§à“¡—Π¬∞“πΣ’Ë 7,350 ∫“Σ à«π„À≠à (96%) ‡§¬¡’‡æ» —¡æ—πΠå ‚¥¬√âÕ¬≈– 68 ¡’ ‡æ» —¡æ—πΠå§√—Èß·√°‡¡◊ËÕÕ“¬ÿ 17-25 ªï à«π„À≠à (87%) ‡§¬§ÿ¡°”‡π‘¥ ·≈–√âÕ¬≈– 94 ‰¡à‡§¬ Ÿ∫∫ÿÀ√’Ë (μ“√“ßΣ’Ë 1) πÕ°®“°π—Èπ ºŸâ√—∫∫√‘°“√√âÕ¬≈– 96 √—∫√Ÿâ¢âÕ¡Ÿ≈ ¢à“« “√‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß ‚¥¬ à«π„À≠à√—∫√Ÿâ®“° ◊ËÕ∫ÿ§§≈À√◊Õ‡®â“Àπâ“Σ’Ë √Õß≈ß¡“ §◊Õ ◊ËÕ “Π“√≥– ‡™àπ ‚Σ√Σ—»πå ‘Ëßæ‘¡æå «‘Σ¬ÿ°√–®“¬ ‡ ’¬ß ‡ªìπμâπ 2. ≈—°…≥–¢ÕߺŸâ„Àâ¢âÕ¡Ÿ≈„π°≈ÿࡺŸâ„Àâ∫√‘°“√ (ºŸâ- ªØ‘∫—μ‘ß“π·≈–ºŸâ∫√‘À“√) 2.1 ºŸâªØ‘∫—μ‘ß“π ·∫∫ Õ∫∂“¡Σ’ˉ¥â√—∫°≈—∫§◊π®“°ºŸâªØ‘∫—μ‘ß“π¡’ ®”π«π 1,525 ™ÿ¥ (Õ—μ√“μÕ∫°≈—∫√âÕ¬≈– 54) æ∫«à“ ºŸâªØ‘∫—μ‘ß“π à«π„À≠à‡ªìπ‡æ»À≠‘ß (92%) ¡’Õ“¬ÿ‡©≈’ˬ 40 ªï ¡’Õ“¬ÿ√–À«à“ß 40-49 ªï (43%) ¥”√ßμ”·Àπàß ‡®â“æπ—°ß“πÀ√◊Õπ—°«‘™“°“√ “Π“√≥ ÿ¢ (51%) ·≈– 欓∫“≈ (48%) à«π„À≠àªØ‘∫—μ‘ß“π„πæ◊ÈπΣ’Ë¡“μ—Èß·μà 5 ªï¢÷Èπ‰ª (58%) ¡’∫Σ∫“Σ√—∫º‘¥™Õ∫ß“πΣ—Èß«“ß·ºπ ¥â“π°“√ à߇ √‘¡ ªÑÕß°—π·≈–ªØ‘∫—μ‘°“√μ√«®§—¥°√Õß «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û μ“√“ßΣ’Ë1 ¢âÕ¡Ÿ≈Σ—Ë«‰ª·≈–æƒμ‘°√√¡ ÿ¢¿“æ¢ÕßÀ≠‘ßμ—«Õ¬à“ß ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– æ◊ÈπΣ’Ëæ—°Õ“»—¬ (n = 4,512 §π) ‡¢μ‡¡◊Õß 1,633 36.2 ‡¢μ„°≈âÀ√◊ÕÀà“߇¡◊Õߪ“π°≈“ß 1,931 42.8 ‡¢μ‰°≈‡¡◊Õß 948 21.0 Õ“¬ÿ (ªï) (n = 4,512 §π) 30-39 1,291 28.6 40-49 1,785 39.6 ≥ 50 1,436 31.8 Mean (SD) / Median (45.7 (8.0) / 46) ∂“π¿“æ (n = 4,505 §π) ‚ ¥ 187 4.2 ¡’§Ÿà·≈–Õ¬Ÿà¥â«¬°—π 3,609 80.1 À¬à“/·¬°°—πÕ¬Ÿà/À¡â“¬ 709 15.7 »“ π“ (n = 4,513 §π) æÿΣΠ 4,273 94.7 §√‘ μå 33 0.7 Õ‘ ≈“¡ 207 4.6 °“√»÷°…“ (n = 4,512 §π) ‰¡à‰¥â»÷°…“ 198 4.4 ª√–∂¡»÷°…“ 3,258 72.1 ¡—Π¬¡»÷°…“μÕπμâπ 429 9.5 ¡—Π¬¡»÷°…“μÕπª≈“¬/ª«™. 359 8.0 Õπÿª√‘≠≠“/ª« . 112 2.5 ª√‘≠≠“μ√’À√◊Õ Ÿß°«à“ 156 3.5 Õ“™’æ (n = 4,512) «à“ßß“π/‰¡à‰¥âª√–°Õ∫Õ“™’æ 248 5.5 ·¡à∫â“π 483 10.7 ‡°…μ√°√√¡ 1,842 40.8 √—∫®â“ß 1,044 23.1 √—∫√“™°“√/æπ—°ß“π√—∞«‘ “À°‘® 63 1.4 æπ—°ß“π‡Õ°™π 25 0.6 §â“¢“¬/Πÿ√°‘® à«πμ—« 807 17.9 ıÙÛ
7.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 μ“√“ßΣ’Ë1(μàÕ) ¢âÕ¡Ÿ≈Σ—Ë«‰ª·≈–æƒμ‘°√√¡ ÿ¢¿“æ¢ÕßÀ≠‘ßμ—«Õ¬à“ß ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– √“¬‰¥â (∫“ΣμàÕ‡¥◊Õπ) (n = 4,512 §π) ≤ 5,000 1,607 35.6 5,000 - 10,000 1,594 35.3 10,001 - 15,000 537 11.9 >15,000 774 17.2 Range / Mean (SD) / Median (250-900,000 / 11,393 (21,027) / 7,350) ª√–«—μ‘°“√¡’‡æ» —¡æ—πΠå (n = 4,512 §π) ‰¡à‡§¬ 170 3.8 ‡§¬ 4,342 96.2 Õ“¬ÿ‡¡◊ËÕ¡’‡æ» —¡æ—πΠå§√—Èß·√° (ªï) (n = 4,335 §π) < 17 834 19.2 17-25 2,933 67.7 > 25 568 13.1 °“√§ÿ¡°”‡π‘¥ (n = 4,338 §π) ‰¡à‡§¬ 579 13.3 ‡§¬·μàªí®®ÿ∫—π‰¡à‰¥â§ÿ¡ 1,257 29.0 ‡§¬·≈–ªí®®ÿ∫—π§ÿ¡ 2,502 57.7 ª√–«—μ‘°“√ Ÿ∫∫ÿÀ√’Ë (n = 4,512 §π) ‰¡à‡§¬ 4,257 94.4 ‡§¬·μàªí®®ÿ∫—π‰¡à‰¥â Ÿ∫ 78 1.7 ‡§¬·≈–ªí®®ÿ∫—π Ÿ∫ 177 3.9 °“√√—∫√Ÿâ¢âÕ¡Ÿ≈¢à“« “√¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß (n = 4,512 §π) ‡§¬ 4,350 96.4 ‰¡à‡§¬ 162 3.6 ·À≈àßΣ’Ë¡“¢Õß°“√‰¥â√—∫¢âÕ¡Ÿ≈¢à“« “√ (n = 4,512 §π) ‡®â“Àπâ“Σ’Ë √æ. μ./√æ. 3,339 74.0 Õ ¡. 970 21.5 ‡æ◊ËÕπ §π√Ÿâ®—°§ÿâπ‡§¬·≈– ¡“™‘°„π§√Õ∫§√—« 938 20.8 ‚Σ√Σ—»πå 2,667 59.1 ◊ËÕ ‘Ëßæ‘¡æå 578 12.8 «‘Σ¬ÿ°√–®“¬‡ ’¬ß/ÀÕ°√–®“¬¢à“« 429 9.5 μ“√“ßΣ’Ë2 ¢âÕ¡Ÿ≈Σ—Ë«‰ª¢ÕߺŸâªØ‘∫—μ‘ß“π„π ∂“π∫√‘°“√ ÿ¢¿“æ ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– ‡æ» (n = 1,525 §π) ™“¬ À≠‘ß Õ“¬ÿ (ªï) (n = 1,522 §π) < 30 30-39 40-49 119 1,406 182 533 656 151 ≥ 50 Mean (SD.) / Median (39.62 (8.1) / 40) μ”·Àπàß (n = 1,524 §π) ‡®â“æπ—°ß“π/π—°«‘™“°“√ “Π“√≥ ÿ¢ 欓∫“≈ Õ◊Ëπ Ê ( Ÿμ‘·æΣ¬å/·æΣ¬åª√–®”∫â“π) Àπâ“Σ’Ë√—∫º‘¥™Õ∫ (n = 1,518 §π) «“ß·ºπ/ à߇ √‘¡/ª√–™“ —¡æ—πΠå μ√«®§—¥°√Õß Σ—Èß Õߥâ“π§«∫§Ÿà°—π ª√– ∫°“√≥å„π°“√ªØ‘∫—μ‘ß“π„πæ◊ÈπΣ’Ë (ªï) (n = 1,479 §π) < 5 ≥ 5 ª√–«—μ‘°“√Õ∫√¡ (n = 1,525 §π) «‘Π’·ªª ‡¡’¬√å 779 725 20 228 99 1,191 619 860 1,222 303 221 1,304 7.8 92.2 12.0 35.0 43.1 9.9 51.1 47.6 1.3 15.0 6.5 78.5 41.9 58.1 ‡§¬ 80.1 ‰¡à‡§¬ 19.9 «‘Π’«’‰Õ‡Õ ‡§¬ 14.5 ‰¡à‡§¬ 85.5 °“√„À⧫“¡ ”§—≠μàÕªí≠À“¡–‡√Áߪ“°¡¥≈Ÿ°„πæ◊ÈπΣ’Ë‡¡ËÕ‡◊Σ’¬∫°—∫ ªí≠À“ ÿ¢¿“æÕ◊Ëπ (n = 1,525 §π) √–¥—∫¡“° 612 √–¥—∫ª“π°≈“ß 688 √–¥—∫πâÕ¬ 226 °“√„À⧫“¡ ”§—≠μàÕ°“√μ√«®§—¥°√Õß (n = 1,525 §π) √–¥—∫¡“° 1,246 √–¥—∫ª“π°≈“ß 241 √–¥—∫πâÕ¬ 38 40.1 45.1 14.8 81.7 15.8 2.5 544 Journal of Health Science 2012 Vol. 21 No. 3
8.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 (79%) ·≈– à«π„À≠àºà“π°“√Õ∫√¡°“√μ√«®§—¥°√Õß ¥â«¬«‘Π’·ªª ‡¡’¬√å (80%) ·μà¡’‡æ’¬ß∫“ß à«πΣ’Ë‡§¬‰¥â √—∫°“√Õ∫√¡°“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ (15%) (μ“√“ßΣ’Ë 2) 2.2 ºŸâ∫√‘À“√ ·∫∫ Õ∫∂“¡Σ’ˉ¥â√—∫§◊π®“°ºŸâ∫√‘À“√¡’®”π«π 418 ™ÿ¥ (Õ—μ√“μÕ∫°≈—∫√âÕ¬≈– 57) æ∫«à“ºŸâ∫√‘À“√ ‚§√ß°“√√–¥—∫®—ßÀ«—¥ à«π„À≠àΣ”ß“π„π‚√ß欓∫“≈ (54%) ‡ªìπ‡æ»À≠‘ß (53%) ¥”√ßμ”·Àπàßπ—°«‘™“°“√ “Π“√≥ ÿ¢ (49%) ¡’√–¬–‡«≈“„π°“√ªØ‘∫—μ‘ß“π„π æ◊ÈπΣ’Ëªí®®ÿ∫—π¡“°°«à“ 10 ªï (53%) ´÷Ëß‚¥¬ à«π„À≠à„Àâ §«“¡ ”§—≠μàÕªí≠À“¡–‡√Áߪ“°¡¥≈Ÿ°¡“°‡¡◊ËÕ‡ª√’¬∫ ‡Σ’¬∫°—∫ªí≠À“ ÿ¢¿“æÕ◊Ëπ Ê (53%) (μ“√“ßΣ’Ë 3) 3. º≈ —¡ƒΣΠ‘Ï¢Õß°“√¥”‡π‘πß“π‚§√ß°“√§—¥°√Õß ¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ æ.». 2548 - æ.». 2552 „π à«π¢ÕßÕ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ¡–‡√Áߪ“°¡¥≈Ÿ°„π 5 ªïΣ’Ëºà“π¡“π—Èπ °≈ÿà¡μ—«Õ¬à“ߢÕß Σÿ°¿“§¡’Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß„°≈⇧’¬ß °—π§◊Õª√–¡“≥√âÕ¬≈– 65-70 ‚¥¬Õ—μ√“°“√‡¢â“√—∫ ∫√‘°“√‡©≈’ˬΣÿ°¿“§„π√–¥—∫ª√–‡Σ» §‘¥‡ªìπ√âÕ¬≈– 68 (95% CI 65, 70) (μ“√“ßΣ’Ë 4) ºŸâ‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß à«π„À≠à (88%) ‰¥â √—∫°“√μ√«®¥â«¬«‘Π’·ªª ‡¡’¬√å ·≈–«‘Π’«’‰Õ‡Õ‡æ’¬ß√âÕ¬≈– 7 ‚¥¬ √æ. μ. ‡ªìπ ∂“π欓∫“≈À≈—°Σ’ËÀ≠‘߇¢â“√—∫∫√‘°“√ (50%) √–¬–‡«≈“√Õº≈À≈—ß√—∫°“√μ√«®§—¥°√Õߥ⫬ «‘Π’·ªª ‡¡’¬√å à«π„À≠à (39%) Õ¬Ÿà√–À«à“ß 2-4 —ª¥“Àå ·≈–√âÕ¬≈– 31 Σ√“∫º≈®“°°“√ÕΠ‘∫“¬¢Õ߇®â“Àπâ“Σ’Ë „π«—πμ√«® §◊Õ ç‡®â“Àπâ“Σ’Ë®–·®âߺ≈„ÀâΣ√“∫‡©æ“– °√≥’æ∫§«“¡º‘¥ª√°μ‘‡Σà“π—Èπé à«πºŸâ√—∫°“√μ√«®¥â«¬ «‘Π’«’‰Õ‡Õ‡°◊Õ∫Σ—ÈßÀ¡¥ (90%) Σ√“∫º≈„π«—πμ√«® (μ“√“ßΣ’Ë 5) “‡Àμÿ¢Õß°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ‰¥â·°à °“√Σ’ËÕ“ “ ¡—§√ “Π“√≥ ÿ¢ À√◊Õ‡®â“Àπâ“Σ’Ë¢Õß √æ. μ./ √æ.·π–π”„À≪μ√«®§—¥°√Õß (50%) μâÕß°“√μ√«® «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û μ“√“ßΣ’Ë3 ¢âÕ¡Ÿ≈Σ—Ë«‰ª¢ÕߺŸâ∫√‘À“√‚§√ß°“√√–¥—∫®—ßÀ«—¥„π ∂“π∫√‘°“√ ÿ¢¿“æ ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– Àπ૬ߓπ/ ∂“πΣ’Ë (n = 401 §π) ®. 12 3.0 Õ. 174 43.4 √æ. 215 53.6 ‡æ» (n = 418) ™“¬ 198 47.4 À≠‘ß 220 52.6 μ”·Àπàß/ “¬ß“π (n = 418 §π) π—°«‘™“°“√ 206 49.3 欓∫“≈ 102 24.4 Ÿμ‘·æΣ¬å 12 2.8 ·æΣ¬å 98 23.5 √–¬–‡«≈“ªØ‘∫—μ‘ß“π„πæ◊ÈπΣ’Ëªí®®ÿ∫—π (ªï) (n = 391 §π) < 5 117 29.9 5 - 10 66 16.9 > 10 208 53.2 °“√„À⧫“¡ ”§—≠μàÕªí≠À“¡–‡√Áߪ“°¡¥≈Ÿ° (n = 418 §π) √–¥—∫πâÕ¬ 77 18.3 √–¥—∫ª“π°≈“ß 118 28.3 √–¥—∫¡“° 223 53.4 §«“¡‡ÀÁπμàÕ°“√¡’ 2 «‘Π’μ√«®§—¥°√Õß¿“¬„π®—ßÀ«—¥ (n = 355 §π) ‡ÀÁπ¥â«¬ 284 80.0 ‰¡à‡ÀÁπ¥â«¬ 36 10.1 ‰¡à· ¥ß§«“¡§‘¥‡ÀÁπ 35 9.9 ÿ¢¿“æ¢Õßμπ‡Õß ‡æ√“– π„® „ à„® ÿ¢¿“æμπ‡Õß À√◊Õ°≈—«‡ªìπ¡–‡√Áߪ“°¡¥≈Ÿ° (38%) ·≈–¡’Õ“°“√º‘¥ ª√°μ‘ ‡™àπ ¡’‡≈◊Õ¥ÕÕ°Σ“ß™àÕߧ≈Õ¥ μ°¢“«º‘¥ª√°μ‘ (11%) à«π “‡ÀμÿÀ≈—°Σ’Ë°≈ÿà¡μ—«Õ¬à“߉¡à‰ªμ√«®§—¥°√Õß ‰¥â·°à °“√Σ’Ë§‘¥«à“μπ‡Õ߉¡à¡’Õ“°“√º‘¥ª√°μ‘ (37%) §‘¥«à“μπ‰¡à‡ ’ˬ߇ªìπ¡–‡√Áߪ“°¡¥≈Ÿ° (23%) ‰¡à¡’‡«≈“ (18%) ·≈–Õ“¬‡®â“Àπâ“Σ’Ë (17%) ıÙı
9.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 μ“√“ßΣ’Ë4 °“√ª√–¡“≥Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¢ÕßÀ≠‘ß°≈ÿࡇªÑ“À¡“¬ ®”π«π ®”π«π Õ—μ√“°“√√—∫ §«“¡§≈“¥‡§≈◊ËÕπ ™à«ß§«“¡‡™◊ËÕ¡—Ëπ °≈ÿà¡ ª√–™“°√À≠‘ß ∫√‘°“√μ√«®„π ¡“μ√∞“π (95%CI) μ—«Õ¬à“ß °≈ÿࡇªÑ“À¡“¬ ª√–™“°√À≠‘ß (SE) lower upper (ª√—∫¥â«¬§à“∂à«ßπÈ”Àπ—°) ‡ªÑ“À¡“¬ (%) Σ—Ë«ª√–‡Σ» μ√«® 3,164 9,137,381 68 1.2 65 70 ‰¡àμ√«® 1,348 4,382,910 32 1.2 30 35 √«¡ 4,512 13,520,291 100 ‡Àπ◊Õ μ√«® 947 1,983,416 70 2.7 64 75 ‰¡àμ√«® 345 866,709 30 2.7 25 36 √«¡ 1,292 2,850,125 100 μ–«—πÕÕ°‡©’¬ß‡Àπ◊Õ μ√«® 705 3,377,522 69 2.1 64 73 ‰¡àμ√«® 267 1,534,455 31 2.1 27 36 √«¡ 972 4,911,977 1.00 °≈“ß/μ–«—πÕÕ°/μ–«—πμ° μ√«® 633 2,500,554 65 2.8 59 71 ‰¡àμ√«® 333 1,344,653 35 2.8 29 41 √«¡ 966 3,845,207 100 „μâ μ√«® 878 1,275,889 67 2.2 62 71 ‰¡àμ√«® 404 637,093 33 2.2 29 38 √«¡ 1,282 1,912,982 100 4. ªí®®—¬Σ’ˇ°’ˬ«¢âÕßμàÕº≈ —¡ƒΣΠ‘Ï¢Õß°“√¥”‡π‘𠂧√ß°“√oe ·∫à߇ªìπªí®®—¬¥â“πºŸâ√—∫∫√‘°“√·≈–ªí®®—¬ ¥â“πºŸâ„Àâ∫√‘°“√ 4.1 ªí®®—¬¥â“πºŸâ√—∫∫√‘°“√ °“√«‘‡§√“–ÀåÀ“ªí®®—¬Σ’Ë¡’º≈μàÕ°“√‡¢â“√—∫ ∫√‘°“√μ√«®§—¥°√ÕߢÕß°≈ÿà¡μ—«Õ¬à“ßæ∫«à“ ªí®®—¬À≈—° Σ’Ë à߇ √‘¡„À⇢â“√—∫∫√‘°“√ ‰¥â·°à °“√√—∫Σ√“∫¢âÕ¡Ÿ≈ °≈à“«§◊Õ °“√Σ’Ë°≈ÿà¡μ—«Õ¬à“߇§¬‰¥â√—∫¢âÕ¡Ÿ≈‡°’ˬ«°—∫ ¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß®–¡’‚Õ°“ ‡¢â“ √—∫°“√μ√«®§—¥°√Õ߇ªìπ 2.5 ‡Σà“¢ÕߺŸâΣ’Ë‰¡à‡§¬‰¥â√—∫ ¢âÕ¡Ÿ≈ (OR 2.5, 95%CI 1.7, 3.8) √Õß≈ß¡“‰¥â·°à §«“¡ ‡¢â“„®‡°’ˬ«°—∫°“√μ√«®§—¥°√Õß ‚¥¬ºŸâΣ’Ë‡¢â“„®∂Ÿ°μâÕß «à“°“√‰ªμ√«®§—¥°√Õ߇ªìπª√–®”μ“¡°”Àπ¥®–Σ”„Àâ ª≈Õ¥¿—¬®“°°“√‡ªìπ¡–‡√Áߪ“°¡¥≈Ÿ° ¡’‚Õ°“ Σ’Ë®–‡¢â“ √—∫∫√‘°“√‡ªìπ 1.7 ‡Σà“¢ÕߺŸâΣ’Ë‡¢â“„®º‘¥ (OR 1.7, 95%CI 1.2, 2.7) πÕ°®“°π’È ªí®®—¬ à«π∫ÿ§§≈ —ߧ¡ ‡»√…∞°‘® ¬—ß¡’§«“¡ ”§—≠μàÕ°“√‡¢â“√—∫°“√μ√«®§—¥°√Õß ‚¥¬ æ∫«à“ºŸâΣ’Ëª√–°Õ∫Õ“™’懰…μ√°√√¡¡’‚Õ°“ ‡¢â“√—∫°“√ μ√«®§—¥°√Õ߇ªìπ 1.9 ‡Σà“¢ÕߺŸâΣ’Ë‰¡à‰¥âΣ”ß“πÀ√◊Õ‡ªìπ ·¡à∫â“π (OR 1.9, 95%CI 1.3, 2.7) ºŸâΣ’ËÕ“»—¬„π‡¢μ 546 Journal of Health Science 2012 Vol. 21 No. 3
10.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 μ“√“ßΣ’Ë5 √“¬≈–‡Õ’¬¥°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– «‘Π’Σ’Ë„™âμ√«®§—¥°√Õß (n =3,164 §π) «‘Π’·ªª ‡¡’¬√å 2,794 88.3 «‘Π’«’‰Õ‡Õ 221 7.0 ‰¡àΣ√“∫«‘Π’ 149 4.7 ∂“πΣ’Ëμ√«® (n =3,164 §π) ∂“π’Õπ“¡—¬/√æ. μ. 1,582 50.0 ‚√ß欓∫“≈¢Õß√—∞ 956 30.2 ‚√ß欓∫“≈À√◊Õ§≈’π‘°‡Õ°™π 471 14.9 Àπ૬∫√‘°“√‡§≈◊ËÕπΣ’Ë 155 4.9 √–¬–‡«≈“Σ√“∫º≈μ√«®«‘Π’·ªª ‡¡’¬√å ( —ª¥“Àå) (n =3,162 §π) < 2 613 19.4 2-4 1,233 39.0 > 4 348 11.0 ·®âߺ≈‡©æ“–À“°μ√«®æ∫§«“¡º‘¥ª√°μ‘ 968 30.6 √–¬–‡«≈“Σ√“∫º≈μ√«®«‘Π’«’‰Õ‡Õ ( —ª¥“Àå) (n =3,158 §π) ‡®â“Àπâ“Σ’Ë·®âߺ≈„π«—πμ√«® °√≥’μâÕß°“√¬◊π¬—πº≈μ√«® 2,833 89.7 < 2 66 2.1 2-4 79 2.5 > 4 63 2.0 ·®âߺ≈‡©æ“–À“°μ√«®æ∫§«“¡º‘¥ª√°μ‘ 117 3.7 “‡ÀμÿÀ≈—°°“√‡¢â“√—∫∫√‘°“√ (n=3,164 §π) ‰¥â√—∫§”·π–π”®“° Õ ¡. ‡®â“Àπâ“Σ’Ë Õ./√æ. μ./√æ. 1,576 49.8 μâÕß°“√μ√«® ÿ¢¿“æ‡æ√“– π„® „ à„® ÿ¢¿“æ °≈—«‡ªìπ‚√§ 1,193 37.7 ¡’Õ“°“√º‘¥ª√°μ‘ ‡™àπ ¡’‡≈◊Õ¥ÕÕ°Σ“ß™àÕߧ≈Õ¥ μ°¢“«º‘¥ª√°μ‘ ‡ªìπμâπ 335 10.6 “¡’À√◊Õ∫ÿ§§≈„°≈♑¥·π–π” 32 1.0 “‡ÀμÿÀ≈—°°“√‰¡à‡¢â“√—∫∫√‘°“√ (n=1,348 §π) ‰¡à¡’Õ“°“√º‘¥ª√°μ‘ 497 36.9 §‘¥«à“μπ‡Õ߉¡à‡ ’ˬßμàÕ°“√‡ªìπ‚√§¡–‡√Áߪ“°¡¥≈Ÿ° 307 22.8 ‰¡à¡’‡«≈“‰ªμ√«®§—¥°√Õß 244 18.1 Õ“¬‡®â“Àπâ“Σ’Ë 222 16.5 ™π∫Σ¡’‚Õ°“ μ√«®§—¥°√Õ߇ªìπ 1.5 ‡Σà“¢ÕߺŸâΣ’ËÕ“»—¬ „π‡¢μ‡¡◊Õß (OR 1.5, 95%CI 1.2, 1.8) ºŸâΣ’Ë¡’Õ“¬ÿ√–À«à“ß 40-49 ªï¡’‚Õ°“ ‡¢â“√—∫°“√μ√«®§—¥°√Õ߇ªìπ 1.5 ‡Σà“ ¢ÕߺŸâΣ’Ë¡’Õ“¬ÿ√–À«à“ß 30-39 ªï (OR 1.5, 95%CI 1.2, «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û 1.8) ·≈–ºŸâΣ’Ë‡§¬μ—Èߧ√√¿å¡’‚Õ°“ Σ’Ë®–‡¢â“√—∫°“√μ√«® §—¥°√Õ߇ªìπ 1.8 ‡Σà“¢ÕߺŸâΣ’Ë‰¡à‡§¬μ—Èߧ√√¿å (OR 1.8, 95%CI 1.2, 2.5) πÕ°®“°π—Èπ¬—ßæ∫ªí®®—¬Σ’ˇªìπÕÿª √√§μàÕ°“√‡¢â“ ıÙ˜
11.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 √ŸªΣ’Ë1 §à“ Odds ratio ·≈–™à«ß§«“¡‡™◊ËÕ¡—ËπΣ’Ë 95% ¢Õßªí®®—¬„πÀ≠‘ß°≈ÿà¡μ—«Õ¬à“ßΣ’Ë —¡æ—πΠå°—∫°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ° √—∫∫√‘°“√μ√«®§—¥°√Õß (√ŸªΣ’Ë 1) ‚¥¬‡©æ“–°“√Σ’Ë°≈ÿà¡ ‡ªÑ“À¡“¬¡’Σ—»π§μ‘Σ’Ë‰¡à¥’μàÕ°“√μ√«®§—¥°√Õß ´÷ËߺŸâΣ’Ë ‡ÀÁπ«à“°“√μ√«®§—¥°√Õ߇ªìπÕ—πμ√“¬¡“° ®–¡’‚Õ°“ ‡¢â“√—∫°“√μ√«®§—¥°√ÕßπâÕ¬°«à“À≠‘ßΣ’Ë‡ÀÁπ«à“‰¡à¡’ Õ—πμ√“¬∂÷ß√âÕ¬≈– 60 (OR 0.4, 95%CI 0.3, 0.7) √«¡Σ—ÈߺŸâΣ’Ë¡’§«“¡√Ÿâ ÷°«‘μ°°—ß«≈¡“°‚¥¬°≈—«®–μ√«® æ∫¡–‡√Áߪ“°¡¥≈Ÿ° ¡’‚Õ°“ μ√«®§—¥°√ÕßπâÕ¬°«à“ À≠‘ßΣ’Ë‰¡à«‘μ°À√◊Õ‰¡à°≈—«‡≈¬√âÕ¬≈– 30 (OR 0.7, 95%CI 0.6, 0.7) „π¥â“𧫓¡√Ÿâ‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈– °“√μ√«®§—¥°√Õß°Áæ∫«à“‡ªìπªí®®—¬Σ’Ë ”§—≠¡“° ‚¥¬ ºŸâΣ’Ë‡¢â“„®º‘¥«à“∂â“μ√«®·≈⫉¡àæ∫§«“¡º‘¥ª√°μ‘°Á‰¡à μâÕß¡“μ√«®Õ’°‡≈¬ ®–¡’‚Õ°“ ‡¢â“√—∫∫√‘°“√πâÕ¬°«à“ ºŸâΣ’Ë¡’§«“¡‡¢â“„®Σ’Ë∂Ÿ°μâÕß√âÕ¬≈– 50 (OR 0.5, 95%CI 0.4, 0.7) „π¢≥–Σ’ËºŸâΣ’Ë‡¢â“„®º‘¥«à“°“√μ√«®§—¥°√Õß Σ”‰¥â„π‚√ß欓∫“≈‡Σà“π—Èπ ¡’‚Õ°“ ‡¢â“√—∫°“√μ√«® §—¥°√ÕßπâÕ¬°«à“À≠‘ßΣ’Ë¡’§«“¡‡¢â“„®Σ’Ë∂Ÿ°μâÕß√âÕ¬≈– 30 (OR 0.7, 95%CI 0.6, 0.9) ·≈–ºŸâΣ’Ë‡¢â“„®º‘¥À√◊Õ‰¡à Σ√“∫‡°’ˬ«°—∫Õ“°“√º‘¥ª√°μ‘¢Õß¡–‡√Áߪ“°¡¥≈Ÿ° ¡’ ‚Õ°“ ‡¢â“√—∫∫√‘°“√πâÕ¬°«à“À≠‘ßΣ’Ë¡’§«“¡‡¢â“„®Σ’Ë∂Ÿ° μâÕß√âÕ¬≈– 20 (OR 0.8, 95%CI 0.7, 0.9) πÕ°®“° π—Èπ¬—ßæ∫«à“ ªí®®—¬ à«π∫ÿ§§≈ —ߧ¡ ‡»√…∞°‘® ·≈– æƒμ‘°√√¡ ÿ¢¿“æ°Á¡’§«“¡ —¡æ—πΠåμàÕ°“√‰¡à‡¢â“√—∫ ∫√‘°“√‡™àπ°—π ‚¥¬ºŸâΣ’Ëπ—∫∂◊ÕÕ‘ ≈“¡®–¡’‚Õ°“ ‡¢â“√—∫ °“√μ√«®§—¥°√ÕßπâÕ¬°«à“ºŸâΣ’Ëπ—∫∂◊Õ»“ π“æÿΣΠ√âÕ¬≈– 40 (OR 0.6, 95%CI 0.5, 0.9) ·≈–ºŸâΣ’Ë Ÿ∫∫ÿÀ√’Ë¡’ ‚Õ°“ ‡¢â“√—∫∫√‘°“√πâÕ¬°«à“ºŸâΣ’Ë‰¡à Ÿ∫√âÕ¬≈– 40 (OR 0.6, 95%CI 0.4, 0.8) 4.2 ªí®®—¬¥â“πºŸâ„Àâ∫√‘°“√ ”À√—∫§«“¡§‘¥‡ÀÁπμàÕπ‚¬∫“¬ªÑÕß°—π¡–‡√Áß ª“°¡¥≈Ÿ°√–¥—∫ª√–‡Σ»π—Èπ ºŸâªØ‘∫—μ‘ß“π‡ÀÁπ«à“¡–‡√Áß ª“°¡¥≈Ÿ°‡ªìπªí≠À“ ”§—≠„π√–¥—∫ª“π°≈“ß (45%) ·≈–√–¥—∫¡“° (40%) ‡¡◊ËÕ‡ª√’¬∫‡Σ’¬∫°—∫ªí≠À“ ÿ¢ ¿“æÕ◊ËπÊ ·≈– à«π„À≠à‡ÀÁπ«à“°“√μ√«®§—¥°√Õ߇ªìπ ·π«Σ“ßΣ’Ë®–™à«¬≈¥Õ—μ√“°“√‡ªìπ¡–‡√Áߪ“°¡¥≈Ÿ°‰¥â¡“° 548 Journal of Health Science 2012 Vol. 21 No. 3
12.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 (82%) (μ“√“ßΣ’Ë 2) ºŸâªØ‘∫—μ‘ß“π¡’§«“¡‡ÀÁπμàÕ«‘Π’·≈–°‘®°√√¡°“√ μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°„πæ◊ÈπΣ’Ë ´÷Ëß à«π„À≠à¡’ §«“¡‡ÀÁπμàÕ°“√μ√«®§—¥°√ÕßΣ—Èß«‘Π’·ªª ‡¡’¬√å·≈– «’‰Õ‡Õ„π‡™‘ß∫«° ‚¥¬‡ÀÁπ¥â«¬„π√–¥—∫ª“π°≈“ßÀ√◊Õ √–¥—∫¡“°‡°◊Õ∫Σÿ°ª√–‡¥Áπ ·μà¡’ºŸâªØ‘∫—μ‘ß“π∫“ß à«π¡’ §«“¡‡ÀÁπ«à“ §«“¡‡æ’¬ßæÕ¢Õß∫ÿ§≈“°√ ß∫ª√–¡“≥ ·≈–§«“¡æ√âÕ¡¥â“πÕÿª°√≥å ‡§√◊ËÕß¡◊Õ ¢ÕßΣ—Èß Õß«‘Π’ §«√‰¥â√—∫°“√ª√—∫ª√ÿß ‚¥¬‡©æ“–®”π«π∫ÿ§≈“°√·≈– °“√®—¥ √√ß∫ª√–¡“≥¢Õß«‘Π’«’‰Õ‡ÕΣ’Ë‡ÀÁπ«à“¡’§àÕπ¢â“ß πâÕ¬ (49% ·≈– 54%) (√ŸªΣ’Ë 2) à«π„π¿“æ√«¡¢Õß°“√¥”‡π‘π°‘®°√√¡°“√μ√«® §—¥°√Õß„πæ◊ÈπΣ’Ë à«π„À≠à‡ÀÁπ¥â«¬„π√–¥—∫ª“π°≈“ß ‰¡à«à“®–‡ªìπª√–‡¥Áπ‡°’Ë¬«°—∫°‘®°√√¡°“√μ√«®§—¥°√Õß Σ’Ëºà“π¡“ °“√ª√–™“ —¡æ—πΠå √–∫∫√âÕ߇√’¬π·≈–°“√ ·°âªí≠À“ °“√π‘‡Σ» μ‘¥μ“¡ ª√–‡¡‘πº≈ ·≈–º≈°“√ ¥”‡π‘πß“πΣ’Ëºà“π¡“ ·μà¡’∫“ߪ√–‡¥ÁπΣ’ËºŸâªØ‘∫—μ‘ß“π ª√–¡“≥√âÕ¬≈– 40 ‡ÀÁπ«à“¬—ß¡’Õ¬Ÿà„π√–¥—∫πâÕ¬ ‡™à𠧫“¡æ√âÕ¡¥â“π‡§√◊ËÕß¡◊Õ Õÿª°√≥å §«“¡‡æ’¬ßæÕ¢Õßß∫ª√–¡“≥ §«“¡‡æ’¬ßæÕ¢Õß∫ÿ§≈“°√ §«“¡√Ÿâ §«“¡™”π“≠¢Õß∫ÿ§≈“°√ §«“¡πà“‡™◊ËÕ¢Õß·μà≈–«‘Π’ §«“¡√«¥‡√Á«„π°“√ àßμàÕ‡æ◊ËÕ«‘π‘®©—¬/√—°…“ §«“¡ ¡∫Ÿ√≥å¢Õß√–∫∫√“¬ß“π °“√„™âª√–‚¬™π宓°∞“π¢âÕ¡Ÿ≈ °“√¬Õ¡√—∫¢Õß°≈ÿࡇªÑ“À¡“¬ °“√ª√– “πß“π„πæ◊ÈπΣ’Ë °“√ π—∫ πÿπ®“°ºŸâ∫√‘À“√ «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û §«“¡‡æ’¬ßæÕ¢Õßß∫ª√–¡“≥„π°“√¥”‡π‘π°‘®°√√¡ ®”π«π·≈–§«“¡ ¡Ë”‡ ¡Õ¢Õß°“√π‘‡Σ»μ‘¥μ“¡®“° à«π°≈“ß ‡ªìπμâπ (√ŸªΣ’Ë 3) „π¢≥–‡¥’¬«°—π ºŸâªØ‘∫—μ‘ß“π à«π„À≠à¡’§«“¡√Ÿâ∂Ÿ° μâÕ߇°Ë’¬«°—∫°“√μ√«®§—¥°√ÕßΣË’‡ªìπ à«π ”§—≠μàÕ°“√ ¥”‡π‘π°‘®°√√¡ ·μଗßæ∫«à“∫“ß à«π¡’§«“¡√Ÿâ·≈– §«“¡‡¢â“„®Σ’˺‘¥„πª√–‡¥Á𠔧—≠ ‚¥¬‡©æ“–Σ’Ë‡°’ˬ«°—∫ «‘Π’·≈–¢—ÈπμÕπ°“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ (μ“√“ßΣ’Ë 6) „π¥â“πºŸâ∫√‘À“√ à«π„À≠à‡¢â“„®π‚¬∫“¬·≈– «—μ∂ÿª√– ߧ尓√μ√«®§—¥°√Õß„π√–¥—∫¡“° (82%) √«¡Σ—È߇ÀÁπ«à“°“√ π—∫ πÿπ®“° à«π°≈“ß °“√«“ß·ºπ ·≈–·π«Σ“ߪؑ∫—μ‘¿“¬„π®—ßÀ«—¥ §ÿ≥¿“æ¢Õß√–∫∫ ¢âÕ¡Ÿ≈·≈–°“√√“¬ß“π ®”π«π∫ÿ§≈“°√·≈–°“√Õ∫√¡ μ≈Õ¥®π°‘®°√√¡°“√μ√«®§—¥°√Õß„πæ◊ÈπΣ’ËΣ’Ëºà“π¡“Õ¬Ÿà „π√–¥—∫ª“π°≈“ß ·μà¡’ºŸâ∫√‘À“√ à«πÀπ÷Ë߇ÀÁπ«à“ ∫ÿ§≈“°√„π√–∫∫¬—ߢ“¥·§≈π (38%) °“√®—¥ √√ß∫ ª√–¡“≥¬—߉¡à‡æ’¬ßæÕ (32%) °“√Õ∫√¡‰¡à ¡Ë”‡ ¡Õ «‘Π’·ªª ‡¡’¬√å«Π‘«’‰’Õ‡Õ √ŸªΣ’Ë2 §«“¡§‘¥‡ÀÁπ¢ÕߺŸâªØ‘∫—μ‘ß“πμàÕ°“√μ√«®¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ‡Õ ıÙ˘
13.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 §«“¡‡æ’¬ßæÕ¢Õßß∫ª√–¡“≥ °“√μ√«®§—¥°√Õ߇ªìπ°“√‡æ‘Ë¡¿“√– ¡’§«“¡√Ÿâ‡æ◊ËÕ∂à“¬ΣÕ¥Õ¬à“߇撬ßæÕ §«“¡∂Ÿ°μâÕß ·¡àπ¬”¢Õß°“√μ√«® §«“¡À≈“°À≈“¬¢Õß°“√„Àâ∫√‘°“√ °‘®°√√¡°“√μ√«® §—¥°√ÕßΣ’Ëºà“π¡“ §«“¡√à«¡¡◊Õ¢Õß Õ ¡. À√◊Õ°≈ÿà¡·¡à∫â“𠧫“¡∂’Ë¢Õß°“√ª√–™“ —¡æ—πΠå §«“¡À≈“°À≈“¬¢Õß ◊ËÕ §«“¡‡À¡“– ¡¢Õß°“√„™â ◊ËÕ °“√ª√–™“ —¡æ—πΠå §«“¡‡æ’¬ßæÕ (®“° à«π°≈“ß) §«“¡ ¡Ë”‡ ¡Õ (®“° à«π°≈“ß) §«“¡‡æ’¬ßæÕ (¿“¬„π®—ßÀ«—¥) §«“¡ ¡Ë”‡ ¡Õ (¿“¬„π®—ßÀ«—¥) °“√π‘‡Σ»μ‘¥μ“¡ ª√–‡¡‘πº≈ °“√¡’ à«π√à«¡¢Õߪ√–™“™π„πæ◊ÈπΣ’Ë §«“¡§√Õ∫§≈ÿ¡°“√„Àâ∫√‘°“√ º≈°“√¥”‡π‘πß“π ¿“æ√«¡ √ŸªΣ’Ë3 §«“¡§‘¥‡ÀÁπ¢ÕߺŸâªØ‘∫—μ‘ß“πμàÕ°‘®°√√¡μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°„πæ◊ÈπΣ’Ë√—∫º‘¥™Õ∫ μ“√“ßΣ’Ë6 §«“¡‡¢â“„®¢ÕߺŸâªØ‘∫—μ‘ß“π‡°’Ë¬«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß ª√–‡¥Á𧫓¡√Ÿâ §«“¡‡¢â“„® ®”π«π √âÕ¬≈– 1. À“°μ√«®§—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å·≈â«æ∫§«“¡º‘¥ª√°μ‘¢Õ߇´≈≈å„π√–¬–°àÕπ ∂Ÿ° 1,378 91.0 ‡ªìπ¡–‡√Áß (CIN1 À√◊Õ LSIL) ‰¡à®”‡ªìπμâÕß√—°…“·μàμâÕß𗥄Àâ¡“μ√«®§—¥°√Õ߇æ◊ËÕ º‘¥ 136 9.0 μ‘¥μ“¡Õ¬à“ß„°≈♑¥ 2. À≠‘ßΣ’Ë‡ªìπ‚√§μ‘¥μàÕΣ“ß‡æ» —¡æ—πΠå ‰¥â·°à ÀŸ¥ÀßÕπ‰°à ´‘øî≈‘ ‰¡à§«√μ√«®§—¥°√Õß ∂Ÿ° 1,300 86.2 º‘¥ 208 13.8 3. À≈—ß®“°«—π ÿ¥Σ⓬¢Õß°“√¡’ª√–®”‡¥◊Õπ‰¡à “¡“√∂μ√«®§—¥°√Õ߉¥âΣ—πΣ’ ∂Ÿ° 1,092 72.8 º‘¥ 409 27.2 4. À“°μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ·≈â«æ∫§«“¡º‘¥ª√°μ‘¢Õ߇´≈≈å„π√–¬–°àÕπ‡ªìπ¡–‡√Áß ∂Ÿ° 698 48.8 μâÕ߉¥â√—∫°“√√—°…“¥â«¬°“√®’ȇ¬ÁπΣ—πΣ’ μâÕßμ‘¥μ“¡º≈·≈–μ√«®´È” º‘¥ 733 51.2 5. °“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ‡À¡“–°—∫À≠‘ß°≈ÿà¡Õ“¬ÿ 30-45 ªï Σ√“∫ 885 62.3 ‰¡àΣ√“∫ 535 37.7 6. À“°μ√«®§—¥°√Õß·≈⫉¡àæ∫§«“¡º‘¥ª√°μ‘μâÕß¡“√—∫°“√μ√«®´È”Σÿ° 5 ªï Σ√“∫ 956 63.6 ‰¡àΣ√“∫ 547 36.4 7. À≠‘ßΣ’Ëμ—¥¡¥≈Ÿ°∫“ß à«π·μଗߧߡ’ª“°¡¥≈Ÿ°‡À≈◊ÕÕ¬Ÿà§«√‡¢â“√—∫°“√μ√«®§—¥°√Õß Σ√“∫ 1,417 93.9 ‡™àπ‡¥’¬«°—∫À≠‘ßΣ’Ë‰¡à‰¥âμ—¥¡¥≈Ÿ° ‰¡àΣ√“∫ 92 6.1 550 Journal of Health Science 2012 Vol. 21 No. 3
14.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 √ŸªΣ’Ë4 §«“¡§‘¥‡ÀÁπ¢ÕߺŸâ∫√‘À“√μàÕπ‚¬∫“¬·≈–°‘®°√√¡°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 5 9 13 39 ♦ √ŸªΣ’Ë5 Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ®”·π°‡ªìπÕ—μ√“°“√ ‡¢â“√—∫∫√‘°“√ – ¡·≈–√“¬ªï (27%) °“√¥”‡π‘π°‘®°√√¡Σ’˺à“π¡“‡ªìπ°“√‡æ‘Ë¡¿“√– „π√–¥—∫ª“π°≈“ß (58%) ·≈–‡æ‘Ë¡¿“√–√–¥—∫¡“° (21%) ‡ªìπμâπ (√ŸªΣ’Ë 4) ºŸâ∫√‘À“√ à«π„À≠à‡§¬√—∫Σ√“∫π‚¬∫“¬°“√μ√«® §—¥°√Õß °≈à“«§◊Õ ∂“π欓∫“≈¿“¬„π®—ßÀ«—¥¢Õßμπ “¡“√∂„Àâ∫√‘°“√μ√«®§—¥°√Õ߉¥âΣ—Èß«‘Π’«’‰Õ‡Õ·≈– ·ªª ‡¡’¬√å (85%) ‚¥¬ºŸâμÕ∫·∫∫ Õ∫∂“¡ à«π„À≠à ‡ÀÁπ¥â«¬°—∫π‚¬∫“¬¥—ß°≈à“« (80%) ·μ৑¥«à“¡’ªí≠À“ «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û ·≈–Õÿª √√§‡°’ˬ«°—∫°“√¢“¥·§≈π∫ÿ§≈“°√ ‚¥¬ ‡©æ“–∫ÿ§≈“°√ºŸâ„Àâ∫√‘°“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ §«“¡πà“‡™◊ËÕ∂◊Õ¢Õß°“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ ª√– ‘ΣΠ‘¿“æ¢Õß°“√∫—πΣ÷°·≈–√“¬ß“πº≈¢âÕ¡Ÿ≈ ·≈– ¿“√–Σ’Ë‡æ‘Ë¡¢÷Èπ¢ÕߺŸâªØ‘∫—μ‘ß“π ‡ªìπμâπ «‘®“√≥å °“√»÷°…“π’Èæ∫Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ¡–‡√Áߪ“°¡¥≈Ÿ°§àÕπ¢â“ß Ÿß Σ—Èß®“°°“√ ”√«®„π°≈ÿà¡ μ—«Õ¬à“ß (70%) ·≈–‡¡◊ËÕª√–¡“≥§à“°“√‡¢â“√—∫∫√‘°“√ μ√«®§—¥°√ÕߢÕß°≈ÿࡇªÑ“À¡“¬„π√–¥—∫ª√–‡Σ» (68%) ´÷Ë߇¡◊ËÕ‡ª√’¬∫‡Σ’¬∫°—∫¢âÕ¡Ÿ≈®“°·À≈àßÕ◊Ëπ ‰¥â·°à √“¬ß“πÕ—μ√“°“√‡¢â“√—∫∫√‘°“√„π√Õ∫ 5 ªï ≥ æ.». 2552 ®“°∞“π¢âÕ¡Ÿ≈¢Õß ∂“∫—π¡–‡√Áß·Ààß™“μ‘ °Áæ∫«à“¡’§à“ „°≈⇧’¬ß°—π §◊Õª√–¡“≥√âÕ¬≈– 70(5) πÕ°®“°π’Ȭ—ß„°≈â ‡§’¬ß°—∫°“√ ”√«® ∂“π°“√≥åÕπ“¡—¬‡®√‘≠æ—πΠÿå·≈– °“√‡¢â“∂÷ß∫√‘°“√¥â“πÕπ“¡—¬Σ—Ë«ª√–‡Σ» „πæ.». 2552 ‚¥¬ ”π—°ß“π ∂‘μ‘·Ààß™“μ‘√à«¡°—∫°√¡Õπ“¡—¬ ´÷Ëß π‚¬∫“¬ §«“¡‡¢â“„®π‚¬∫“¬·≈–«—μ∂ÿª√– ߧå ß∫ª√–¡“≥Σ’Ë‰¥â√—∫®—¥ √√‡æ’¬ßæÕ ¥â“π«‘™“°“√ ‡™àπ °“√®—¥Õ∫√¡°“√μ√«®§—¥°√Õß °“√ π—∫ πÿπ ®“° à«π°≈“ß °“√ª√– “πß“π‡æ◊ËÕ«“ß·ºπªØ‘∫—μ‘ß“π §«“¡æ√âÕ¡„Àâ∫√‘°“√ √–∫∫°“√ àßμàÕ àßμ√«®√—°…“ §«“¡√à«¡¡◊Õ¢ÕßÀπ૬ߓπΣ’Ë‡°’ˬ«¢âÕß °“√ªØ‘∫—μ‘ß“π ¿“¬„π®—ßÀ«—¥ °“√®—¥°“√¢âÕ¡Ÿ≈ °“√∫—πΣ÷° °“√„™â‚ª√·°√¡ ‡ªìπμâπ °“√√“¬ß“𠇙à𠧫“¡∂Ÿ°μâÕß §√∫∂â«π Σ—π‡«≈“ §ÿ≥¿“æ¢Õß √–∫∫¢âÕ¡Ÿ≈ §«“¡‡æ’¬ßæÕ¢Õß∫ÿ§≈“°√ °“√Õ∫√¡°“√μ√«®§—¥°√ÕßÕ¬à“ß ¡Ë”‡ ¡Õ °“√‡æ‘Ë¡¿“√–„Àâ°—∫∫ÿ§≈“°√ ∫ÿ§≈“°√ §«“¡®”‡ªìπΣ’ËμâÕß¡’°“√μ√«®§—¥°√Õß §«“¡À≈“°À≈“¬¢Õß°‘®°√√¡„Àâ∫√‘°“√ °‘®°√√¡°“√μ√«® §—¥°√Õß Õ—μ√“°“√‡¢â“√—∫“∫√‘°“√μ√«®§—¥°√Õß·μà≈–ªï Õ—μ√“°“√‡¢â“√—∫“∫√‘°“√μ√«®§—¥°√Õß – ¡ √âÕ¬≈– ♦ ♦ ♦ ♦ ♦ 7 65 2 16 29 æ.». 2548 æ.». 2549 æ.». 2550 æ.». 2551 æ.». 2552 ııÒ
15.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 · ¥ß„Àâ‡ÀÁπ«à“ ºŸâΣ’Ë¡’Õ“¬ÿ 30-59 ªï‡¢â“√—∫∫√‘°“√μ√«® §—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°„π√Õ∫ 5 ªïΣ’Ëºà“π¡“§‘¥‡ªìπ ª√–¡“≥√âÕ¬≈– 60(10) √«¡Σ—Èßæ∫«à“ºŸâΣ’ËÕ“»—¬Õ¬Ÿà„π °√ÿ߇Σæ¡À“π§√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß„πÕ—μ√“μË” Σ’Ë ÿ¥ §◊Õ√âÕ¬≈– 44 ¢≥–Σ’Ë¿“§Õ◊Ëπ¡’°“√‡¢â“√—∫∫√‘°“√ μ√«®§—¥°√Õß¡“°°«à“ §◊Õ √âÕ¬≈– 60-69 ”À√—∫°“√ »÷°…“π’ȺŸâ«‘®—¬‰¡à‰¥âΣ”°“√ ”√«®„πÀ≠‘ß°≈ÿࡇªÑ“À¡“¬ ®—ßÀ«—¥°√ÿ߇Σæoe ®÷ßÕ“®‡ªìπº≈„Àâæ∫Õ—μ√“°“√‡¢â“√—∫ ∫√‘°“√μ√«®§—¥°√Õß„π¿“æ√«¡√–¥—∫ª√–‡Σ» Ÿß°«à“ §«“¡‡ªìπ®√‘߉¥â º≈°“√ ”√«®®“°°“√»÷°…“π’È(8) ·≈–°“√√“¬ß“π ®“°∞“π¢âÕ¡Ÿ≈¢Õß ∂“∫—π¡–‡√Áß·Ààß™“μ‘(5) √«¡Σ—Èß°“√ ”√«®¢Õß ”π—°ß“π ∂‘μ‘·Ààß™“μ‘√à«¡°—∫°√¡ Õπ“¡—¬(10) „π√Õ∫ 5 ªï Σ’Ë¡’Õ—μ√“°“√‡¢â“√—∫∫√‘°“√Σ’Ë‡æ‘Ë¡ Ÿß¢÷Èππ’È Õ“® –ΣâÕπ«à“ °√–Σ√«ß “Π“√≥ ÿ¢·≈– Àπ૬ߓπΣ’Ë‡°’ˬ«¢âÕß‚¥¬‡©æ“–Õ¬à“߬‘Ëß ª ™.‰¥â ª√—∫ª√ÿß°“√®—¥∫√‘°“√‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ°„À⥒¢÷ÈπÕ¬à“ß™—¥‡®π ºŸâ∫√‘À“√ ºŸâªØ‘∫—μ‘ß“π √«¡Σ—Èß°≈ÿࡇªÑ“À¡“¬„À⧫“¡ ”§—≠μàÕªí≠À“¡–‡√Áß ª“°¡¥≈Ÿ° ´÷Ëß àߺ≈„Àâ°≈ÿࡇªÑ“À¡“¬‡¢â“√—∫∫√‘°“√μ√«® §—¥°√Õ߇æ‘Ë¡¢÷Èπ π—ÈπÀ¡“¬∂÷ß°‘®°√√¡Σ’Ë¥”‡π‘π°“√¿“¬ „μ₧√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬ «‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ æ.». 2548 - æ.». 2552 Σ”„Àâ Õ—μ√“°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°„πª√–‡Σ»‰Σ¬ ‡æ‘Ë¡ Ÿß¢÷Èπ ‚¥¬‡©æ“–Õ¬à“߬‘Ëß„π™à«ß 1-2 ªïΣ’Ëºà“π¡“ (æ.». 2551-2552) ¥—ß· ¥ß„π√ŸªΣ’Ë 5 „π™à«ß‡«≈“¥—ß°≈à“«π’È ¡’°“√‡æ‘Ë¡√Ÿª·∫∫·≈–«‘Π’°“√√≥√ß§å ª√–™“ —¡æ—πΠå ®“°À≈“°À≈“¬™àÕßΣ“ß®“°Àπà«¬ß“π¿“§√—∞ πÕ°®“° π—Èπ¡’°“√ π—∫ πÿπ¥â“πß∫ª√–¡“≥‡æ◊ËÕ √â“ß·®ß®Ÿß„Àâ ·°à∫ÿ§≈“°√ºŸâ„Àâ∫√‘°“√°ÁÕ“®¡’º≈μàÕ°“√‡æ‘Ë¡¢÷Èπ¢Õß Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õ߇™àπ°—π ‚¥¬¢≥– Σ’ËΣ”°“√»÷°…“¡’Õ—μ√“§à“μÕ∫·Σπ°“√„Àâ∫√‘°“√μ√«® §—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å§√—Èß≈– 250 ∫“Σ ·≈–«‘Π’ «’‰Õ‡Õ§√—Èß≈– 70 ∫“Σ ´÷ËßÕ—μ√“¥—ß°≈à“«¬—߉¡à√«¡°“√ √—°…“‡¡◊ËÕæ∫§«“¡º‘¥ª√°μ‘ πÕ°®“°°“√‡æ‘Ë¡°“√√≥√ߧåª√–™“ —¡æ—πΠå·≈â« ªí®®—¬¥â“πºŸâ√—∫∫√‘°“√Σ’Ë‡°’ˬ«¢âÕß°—∫°“√√—∫√Ÿâ √«¡Σ—Èß Σ—»π§μ‘μàÕ¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß°Á¡’ §«“¡ ”§—≠μàÕ§«“¡ ”‡√Á®¢Õß‚§√ß°“√oe ‡π◊ËÕß®“° ‡ªìπªí®®—¬Σ’Ë°”Àπ¥°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ¡–‡√Áߪ“°¡¥≈Ÿ° ·∫à߇ªìπ 2 ≈—°…≥–§◊Õªí®®—¬ à߇ √‘¡ ·≈–ªí®®—¬Σ’ˇªìπÕÿª √√§μàÕ°“√‡¢â“√—∫∫√‘°“√ ´÷Ë߇ªìπ ‰ªμ“¡·∫∫·ºπ§«“¡‡™◊ËÕ¥â“π ÿ¢¿“æ (health belief model)(11) Σ’Ë«à“∫ÿ§§≈Σ’Ë®–¡’æƒμ‘°√√¡À≈’°‡≈’ˬ߮“°‚√§ ®–μâÕß¡’§«“¡‡™◊ËÕ«à“μπ‡Õß¡’‚Õ°“ ‡ ’ˬßμàÕ°“√‡ªìπ‚√§ ‡™◊ËÕ«à“‚√§π—Èπ¡’§«“¡√ÿπ·√ß·≈–¡’º≈°√–Σ∫μàÕ°“√ ¥”‡π‘π™’«‘μ √«¡Σ—È߇™◊ËÕ«à“°“√ªØ‘∫—μ‘μ—«‡æ◊ËÕÀ≈’°‡≈’Ë¬ß μàÕ°“√‡ªìπ‚√§π—Èπ®–‡°‘¥º≈¥’„π°“√≈¥‚Õ°“ ‡ ’ˬßμàÕ °“√‡ªìπ‚√§À√◊ՙ૬≈¥§«“¡√ÿπ·√ߢÕß‚√§ ‚¥¬‰¡à §«√¡’Õÿª √√§¥â“π®‘μ«‘Σ¬“¡“‡°’ˬ«¢âÕß °“√»÷°…“¢Õß Lazcano-Ponce EC. ·≈–§≥–(12) æ∫«à“°“√‰¥â√—∫¢âÕ¡Ÿ≈¢à“« “√·≈–¡’§«“¡‡¢â“„®μàÕ «—μ∂ÿª√– ߧ尓√μ√«®§—¥°√Õß ‡ªìπªí®®—¬Σ’Ë π—∫ πÿπ „Àâ°≈ÿࡇªÑ“À¡“¬‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß πÕ°®“° π—Èπ°“√»÷°…“¢Õß Phipps E. ·≈–§≥–(13) ·≈– Boopongmanee ·≈–§≥–(14) æ∫«à“°“√Õ“»—¬Õ¬Ÿà„π ‡¢μ™π∫Σ °“√‰¥â√—∫¢âÕ¡Ÿ≈¢à“« “√ °“√ª√–°Õ∫Õ“™’æ ‡°…μ√°√√¡ §«“¡√Ÿâ·≈–Σ—»π§μ‘Σ’Ë¥’μàÕ°“√μ√«®§—¥ °√Õß·≈–‡®â“Àπâ“Σ’Ë ≈â«π‡ªìπªí®®—¬μàÕ°“√‡¢â“√—∫∫√‘°“√ μ√«®§—¥°√Õß ´÷Ëß Õ¥§≈âÕß°—∫º≈°“√»÷°…“„π§√—Èßπ’È à«πªí®®—¬Σ’ˇªìπÕÿª √√§À√◊Õ¢—¥¢«“ßμàÕ°“√‰ªμ√«® §—¥°√Õß ‡™à𠧫“¡√ŸâΣ’Ëº‘¥‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈– °“√μ√«®§—¥°√Õß Σ—»π§μ‘Σ’Ë‰¡à¥’μàÕ«‘Π’°“√μ√«®§—¥°√Õß º≈°“√»÷°…“¥—ß°≈à“«¡’§«“¡ Õ¥§≈âÕß°—∫ß“π«‘®—¬¢Õß Schulmeister L. ·≈–§≥–(15) Deschamps M. ·≈– §≥–(16) ·≈– Carter J. ·≈–§≥–(17) ´÷Ëß°“√»÷°…“‡À≈à“ π’È √ÿªº≈‰¥â«à“À≠‘ßΣ’Ë‰¡à¡’§«“¡√Ÿâ §«“¡‡¢â“„®‡°’ˬ«°—∫ ¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√ÕßΣ’Ë¥’æÕ ®–‰¡à ‡°‘¥§«“¡μ√–Àπ—°μàÕ ÿ¢¿“æÀ√◊Õªí≠À“ ·≈–¡’‚Õ°“ ‡¢â“√—∫°“√μ√«®§—¥°√ÕßπâÕ¬°«à“À≠‘ßΣ’Ë¡’§«“¡√Ÿâ §«“¡ 552 Journal of Health Science 2012 Vol. 21 No. 3
16.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ‡¢â“„®Σ’Ë¥’ πÕ°®“°π—Èπ°“√»÷°…“§√—Èßπ’Èæ∫«à“ “‡Àμÿ¢Õß °“√‰¡à√—∫∫√‘°“√μ√«®§—¥°√Õ߇ªìπ‡æ√“–‰¡à¡’Õ“°“√º‘¥ ª√°μ‘ ‰¡à¡’‡«≈“μ√«® Õ“¬Σ’Ë®–μ√«® ‰¡à§‘¥«à“μπ‡Õß ‡ ’ˬ߇ªìπ¡–‡√Áß ·≈–°≈—«μ√«®æ∫‡ªìπ¡–‡√Áߪ“°¡¥≈Ÿ° Õ¥§≈âÕß°—∫¢âÕ§âπæ∫®“°ß“π«‘®—¬¢Õß Lee-Lin F. ·≈–§≥–(18) Steven D. ·≈–§≥–(19) Σ’Ëæ∫ “‡Àμÿ°“√ ‰¡à‡¢â“√—∫∫√‘°“√μ√«®§—¥°√ÕߢÕßÀ≠‘ß°≈ÿà¡μ—«Õ¬à“ß„π ≈—°…≥–‡¥’¬«°—π º≈°“√»÷°…“¥â“πªí®®—¬„π°≈ÿࡇªÑ“À¡“¬Σ’Ë°≈à“« ¢â“ßμâπ· ¥ß„Àâ‡ÀÁπ«à“ „π°“√¥”‡π‘π‚§√ß°“√oe ‡æ◊ËÕ ‡æ‘Ë¡Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“° ¡¥≈Ÿ°π—Èπ ºŸâ„Àâ∫√‘°“√®–μâÕßæ‘®“√≥“·≈–Σ”§«“¡ ‡¢â“„®μàÕ≈—°…≥–‡©æ“–¢Õß°≈ÿࡇªÑ“À¡“¬ Σ’Ë¡’§«“¡ ·μ°μà“ß°—π„π·μà≈–æ◊ÈπΣ’Ë Σ—Èߥâ“π°“√√—∫√Ÿâ·≈–Σ—»π§μ‘ ¥â“πæƒμ‘°√√¡ ÿ¢¿“æ §«“¡¬“° ≈”∫“°„π°“√‡¥‘π Σ“ß‡æ◊ËÕ‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß √«¡Σ—Èß«‘∂’°“√ ¥”‡π‘π™’«‘μ·≈–«—≤πΠ√√¡ ¥—ßπ—Èπ°“√æ—≤π“«‘Π’À√◊Õ °≈¬ÿΣΠå„π°“√ à߇ √‘¡ ª√–™“ —¡æ—πΠå·≈–°“√„Àâ ∫√‘°“√μâÕß¡’§«“¡®”‡æ“–·≈–·μ°μà“߉ªμ“¡≈—°…≥– ¢Õß·μà≈–æ◊ÈπΣ’Ë ´÷Ëߧ«√æ—≤π“«‘Π’À√◊Õ°≈¬ÿΣΠ凙‘ß√ÿ° ‚¥¬¡ÿà߇πâπ‡æ‘Ë¡°“√‡¢â“∂÷ߢâÕ¡Ÿ≈·≈–‡¢â“∂÷ß∫√‘°“√¢Õß ºŸâ√—∫∫√‘°“√ ¥â“πºŸâ„Àâ∫√‘°“√ æ∫ªí®®—¬Σ’Ë à߇ √‘¡„À₧√ß°“√oe ¡’·π«‚π⡪√– ∫§«“¡ ”‡√Á® ‰¥â·°à °“√‡ÀÁ𧫓¡ ”§—≠¢Õߪí≠À“¡–‡√Áߪ“°¡¥≈Ÿ°¢ÕߺŸâ∫√‘À“√·≈– ºŸâªØ‘∫—μ‘ß“π Õ’°Σ—Èßæ∫«à“ºŸâ∫√‘À“√·≈–ºŸâªØ‘∫—μ‘ß“π¡’ §«“¡‡ÀÁπ Õ¥§≈âÕß°—π«à“°“√μ√«®§—¥°√Õß¡–‡√Áߪ“ °¡¥≈Ÿ°‡ªìπ·π«Σ“ßΣ’Ë®”‡ªìπ„π°“√·°âªí≠À“ πÕ°®“° π—ÈπºŸâ∫√‘À“√¡’§«“¡‡¢â“„®π‚¬∫“¬·≈–«—μ∂ÿª√– ߧ尓√ μ√«®§—¥°√Õ߇ªìπÕ¬à“ߥ’ °“√„À⧫“¡ ”§—≠·≈–§«“¡ ‡¢â“„®‡À≈à“π’ȇªìπªí®®—¬æ◊Èπ∞“𠔧—≠¢Õß°“√æ—≤π“ °≈¬ÿΣΠå„π°“√¥”‡π‘πß“π·≈–Σ”„Àâ “¡“√∂¢—∫‡§≈◊ËÕπ π‚¬∫“¬√–¥—∫®—ßÀ«—¥‰¥â ·μຟâªØ‘∫—μ‘ß“π·≈–ºŸâ∫√‘À“√ à«πÀπ÷Ë߇ÀÁπ«à“®”π«π∫ÿ§≈“°√ ß∫ª√–¡“≥ ®”π«π °“√§«∫§ÿ¡§ÿ≥¿“扡à‡æ’¬ßæÕμàÕ°“√¥”‡π‘π‚§√ß°“√ «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û ¿“¬„π®—ßÀ«—¥ √«¡Σ—Èß∫“ß à«π‡ÀÁπ«à“√–∫∫¢âÕ¡Ÿ≈¬—ß ‰¡à¡’ª√– ‘ΣΠ‘¿“æ¡“°π—° ¥—ßπ—ÈπÀ“°‰¥â√—∫ª√—∫ª√ÿß‚¥¬ ‡æ‘Ë¡®”π«π°“√Õ∫√¡‡æ◊ËÕ‡æ‘Ë¡∫ÿ§≈“°√À√◊ÕÕ∫√¡øóôπøŸ ·°à∫ÿ§≈“°“√Σ’Ë‡§¬Õ∫√¡ ‡æ‘Ë¡°“√§«∫§ÿ¡§ÿ≥¿“æ°“√ μ√«®§—¥°√Õß®“° à«π°≈“ß ®–‡ªìπ°“√‡ √‘¡ªí®®—¬π” ‡¢â“¥â“π°“√„Àâ∫√‘°“√Σ’Ë‡Õ◊ÈÕμàÕ§«“¡ ”‡√Á®‚§√ß°“√ √«¡Σ—ÈßÀ“°¡’°“√ª√—∫ª√ÿß√–∫∫¢âÕ¡Ÿ≈‡æ◊ËÕ‡™◊ËÕ¡‚¬ß √–À«à“ß°“√μ√«®§—¥°√Õß°—∫°“√μ‘¥μ“¡ºŸâ¡’º≈‡´≈≈庑¥ ª√°μ‘„Àâ¡’ª√– ‘ΣΠ‘¿“æ ®–‡ªìπ°≈¬ÿΣΠåΣ’ËΣ”„Àâ¡’¢âÕ¡Ÿ≈Σ’Ë ∂Ÿ°μâÕß·≈–‡æ’¬ßæÕ„π°“√«“ß·ºπ°“√¥”‡π‘π‚§√ß°“√ „Àâª√– ∫§«“¡ ”‡√Á®μ“¡‡ªÑ“À¡“¬‰¥â¥’¬‘Ëߢ÷Èπ ´÷Ëß®“° §”·π–π”¢Õß International Agency for Research on Cancer: IARC(14) √–∫ÿ«à“°“√æ—≤π“°≈¬ÿΣΠå°“√ §«∫§ÿ¡·≈–ªÑÕß°—π¡–‡√Áߪ“°¡¥≈Ÿ°‡æ◊ËÕ„À⇰‘¥º≈º≈‘μ ·≈–º≈≈—æΠåÕ¬à“ß¡’ª√– ‘ΣΠ‘¿“æ®–μâÕߥ”‡π‘π°“√‡ªìπ √–∫∫·≈–¡’§«“¡æ√âÕ¡„πΣÿ°¢—ÈπμÕπ ‡√‘Ë¡μ—Èß·μà°“√ æ—≤π“Σ“ß¥â“ππ‚¬∫“¬ ªí®®—¬π”‡¢â“ ·≈–°√–∫«π°“√ À√◊Õ°‘®°√√¡¥”‡π‘πß“π ´÷Ëß¡’À≈“¬ß“π«‘®—¬Σ’ˇÀÁπ Õ¥§≈âÕßμ√ß°—π«à“ªí®®—¬¥â“π√–∫∫∫√‘°“√¡’º≈μàÕ°“√ ‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß·≈–°“√‡¢â“√—∫°“√√—°…“(20-22) „π¢≥–‡¥’¬«°—π º≈°“√»÷°…“π’È°Á‰¥â· ¥ß„Àâ‡ÀÁπ«à“ ªí®®—¬æ◊Èπ∞“π‚¥¬‡©æ“–‚§√ß √â“ߢÕßÀπ૬∫√‘°“√¬—ß ‡ªìπªí≠À“·≈–Õÿª √√§„π°“√ªØ‘∫—μ‘ß“π ªí≠À“°“√ ¢“¥·§≈π∫ÿ§≈“°√·≈–°“√®—¥ √√ß∫ª√–¡“≥„π°“√ „Àâ∫√‘°“√¥â«¬«‘Π’«’‰Õ‡Õ„π®—ßÀ«—¥Σ’Ë¡’°“√μ√«®§—¥°√Õß Σ—Èß Õß«‘Π’ ¥â«¬¢âÕ®”°—¥¥â“π°“√‡æ‘Ë¡∫ÿ§≈“°√ ‰¥â·°à §ÿ≥ ¡∫—μ‘¢ÕߺŸâ‡¢â“√—∫°“√Õ∫√¡Σ’ËμâÕ߇ªìπ欓∫“≈ «‘™“™’æ·≈–μâÕß√—∫°“√Õ∫√¡®“°Àπ૬ߓπΣ’Ë°√¡ Õπ“¡—¬¡Õ∫À¡“¬μ“¡°√Õ∫√–¬–‡«≈“·≈–¡“μ√∞“πΣ’Ë °”Àπ¥ ®÷ßΣ”„Àâ¡’®”π«π∫ÿ§≈“°√«’‰Õ‡Õ‰¡à‡æ’¬ßæÕμàÕ °“√„Àâ∫√‘°“√ à«π°“√®—¥ √√ß∫ª√–¡“≥μ“¡«‘Π’°“√ μ√«®§—¥°√Õß‚¥¬®à“¬„Àâ°—∫æ◊ÈπΣ’Ë·≈–∫ÿ§≈“°√ ºŸâ„Àâ ∫√‘°“√‡ÀÁπ«à“¡’§«“¡‡À≈◊ËÕ¡≈È” ‚¥¬«‘Π’«’‰Õ‡Õ‰¥â√—∫°“√ ®—¥ √√¥â“πß∫ª√–¡“≥πâÕ¬°«à“«‘Π’·ªª ‡¡’¬√å Σ”„Àâ ºŸâ∫√‘À“√ ∂“π欓∫“≈À√◊Õ·¡â·μຟâªØ‘∫—μ‘ß“π‰¡à¡’·√ß ııÛ
17.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 ®Ÿß„®Σ’Ë®–‡≈◊Õ°„™â«‘Π’«’‰Õ‡Õ„πæ◊ÈπΣ’Ë ∂÷ß·¡â®–‡ªìπ«‘Π’Σ’Ë √«¥‡√Á«·≈–ºŸâ√—∫∫√‘°“√‰¡àμâÕß°—ß«≈‡√◊ËÕß√Õº≈μ√«®(8) πÕ°®“°π—Èπæ∫«à“¬—ß¡’ºŸâ„Àâ∫√‘°“√∫“ß à«π‡¢â“„®º‘¥À√◊Õ ‰¡àΣ√“∫‡°’ˬ«°—∫«‘Π’·≈–¢—ÈπμÕπ°“√μ√«®§—¥°√Õߥ⫬ «‘Π’«’‰Õ‡Õ Σ—ÈßΣ’Ë‡ªìπ«‘Π’À≈—°πÕ°‡Àπ◊Õ®“°«‘Π’·ªª ‡¡’¬√å ´÷Ëß°”Àπ¥„Àâ„™â„π‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ ¥—ßπÈ—π∂÷ß·¡âæÈ◊πΣË’ π—Èπ Ê ‰¡à‰¥â„Àâ∫√‘°“√¥â«¬«‘Π’«’‰Õ‡Õ°Áμ“¡ ∫ÿ§≈“°√§«√ ‰¥â√—∫°“√Õ∫√¡§«“¡√Ÿâæ◊Èπ∞“πΣ—Èß Õß«‘Π’§«∫§Ÿà°—π ‡æ◊ËÕ Σ’Ë®–‰¥â ◊ËÕ “√°—∫ª√–™“™π‰¥â∂Ÿ°μâÕß ¢âÕ‡ πÕ·π–‡™‘ßπ‚¬∫“¬ 1) ‡æ‘Ë¡°“√ ◊ËÕ “√‡æ◊ËÕ à߇ √‘¡§«“¡√Ÿâ·≈–Σ—»π§μ‘ ‚¥¬¥”‡π‘π°“√Õ¬à“ßμàÕ‡π◊ËÕß·≈–ÕÕ°·∫∫„Àâ®”‡æ“– μàÕ≈—°…≥–¢Õß°≈ÿࡇªÑ“À¡“¬·≈–ª√–™“™πΣ—Ë«‰ª„π ·μà≈–æ◊ÈπΣ’Ë Õ“Σ‘ ‡¢μ™π∫Σ·≈–æ◊ÈπΣ’ËÀà“߉°≈ §«√ ª√–™“ —¡æ—πΠåºà“π ◊ËÕ™ÿ¡™πÀ√◊Õ ◊ËÕ™“«∫â“π√«¡°—∫ °√–μÿâπºà“π ◊ËÕÕ◊Ëπ Ê ‡¢μ‡¡◊Õß ·≈–°≈ÿࡇ©æ“– ‡™àπ ºŸâΣ’Ë Ÿ∫∫ÿÀ√’Ë §«√‡æ‘Ë¡°“√ª√–™“ —¡æ—πΠå‚¥¬‡πâπ°“√„™â ◊ËÕ “Π“√≥–·≈–°“√‡¢â“∂÷ß ∂“πΣ’ËΣ”ß“π ∂“πΣ’Ë “Π“√≥–Σ’Ë ”§—≠ ·≈–√≥√ߧå√à«¡°—∫Õߧå°√æ—≤π“ ‡Õ°™πÀ√◊ÕÀπ૬ߓπμà“ß Ê 2) ª√—∫√Ÿª·∫∫°“√„Àâ∫√‘°“√„π°≈ÿà¡Σ’Ë¡’§«“¡ §√Õ∫§≈ÿ¡μË” Õ“Σ‘ À≠‘ß¡ÿ ≈‘¡ §«√®—¥∫√‘°“√„π™à«ßΣ’Ë ‰¡à¢—¥·¬âßμàÕæ‘Π’°√√¡Σ“ß»“ π“ ‡™àπ ™à«ß∂◊Õ»’≈Õ¥ °“√ª√–°Õ∫æ‘Π’OE—®¬å √â“ߧ«“¡‡¢â“„®·≈–ª√—∫Σ—»π§μ‘ ‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√ªÑÕß°—π°—∫À—«Àπâ“ §√Õ∫§√—«·≈–ºŸâπ”»“ π“ ‡ªìπμâπ ºŸâΣ’ËÕ“»—¬Õ¬Ÿà„π‡¢μ ‡¡◊Õß §«√®—¥∫√‘°“√‡™‘ß√ÿ°„À⇢â“∂÷ß ∂“πΣ’ËΣ”ß“π ®—¥ ∫√‘°“√„π«—πÀ¬ÿ¥‡ “√å-Õ“Σ‘μ¬å ‡æ‘Ë¡§«“¡√à«¡¡◊Õ°—∫ ¿“§‡Õ°™π„À⺟â√—∫∫√‘°“√ “¡“√∂‡¢â“√—∫∫√‘°“√„π ∂“π ∫√‘°“√„°≈â∫â“π‰¥â‚¥¬‰¡à‡ ’¬§à“„™â®à“¬ à«πºŸâΣ’ËÕ“»—¬„π æ◊ÈπΣ’ËÀà“߉°≈ §«√®—¥∫√‘°“√„À⇢â“∂÷ß·≈–Õ“®‡ √‘¡·√ß °√–μÿâπ¥â«¬°“√ √â“ß·√ß®Ÿß„®„Àâμ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ°√à«¡°—∫°“√μ√«®§—¥°√Õß‚√§À√◊Õ°“√ à߇ √‘¡ ÿ¢¿“æÕ◊Ëπ Ê æ√âÕ¡°—π„π§√“«‡¥’¬« 3) ®—¥Õ∫√¡øóôπøŸ°“√μ√«®§—¥°√Õߥ⫬«‘Π’ ·ªª ‡¡’¬√å·≈–«’‰Õ‡Õ·°àºŸâªØ‘∫—μ‘ß“πÕ¬à“ßπâÕ¬ªï≈– 1 §√—Èß ¡’°“√§«∫§ÿ¡§ÿ≥¿“æ°“√Σ”ß“πÕ¬à“ß ¡Ë”‡ ¡Õ √«¡ Σ—Èßæ—≤𓂪√·°√¡§Õ¡æ‘«‡μÕ√å‡æ◊ËÕ°“√∫—πΣ÷°·≈– √“¬ß“π¢âÕ¡Ÿ≈ ‚¥¬ “¡“√∂‡™◊ËÕ¡‚¬ß√–∫∫°“√μ√«®§—¥ °√Õß°—∫√–∫∫§âπÀ“ºŸâ‰¡à‡§¬μ√«® √–∫∫μ‘¥μ“¡„π°≈ÿà¡ ºŸâ¡’º≈‡´≈≈庑¥ª√°μ‘‡æ◊ËÕ√—∫°“√√—°…“Õ¬à“ßμàÕ‡π◊ËÕ߉¥â ·≈–¡’°“√Õ∫√¡‡®â“Àπâ“Σ’Ë ‡ΩÑ“μ‘¥μ“¡À√◊Õ°”°—∫ §ÿ≥¿“æ¢Õß°“√∫—πΣ÷°¢âÕ¡Ÿ≈Õ¬à“ß ¡Ë”‡ ¡Õ 4) ”π—°ß“πÀ≈—°ª√–°—π ÿ¢¿“æ·Ààß™“μ‘·≈– °√–Σ√«ß “Π“√≥ ÿ¢§«√¡’§«“¡™—¥‡®π„ππ‚¬∫“¬·≈– °“√°”Àπ¥‡ªÑ“À¡“¬√–¬–¬“«‡æ◊ËÕ≈¥§«“¡‡®Á∫ªÉ«¬ ·≈–°“√‡ ’¬™’«‘μ®“°¡–‡√Áߪ“°¡¥≈Ÿ° πÕ°®“°π—ÈπμâÕß ¡’§«“¡™—¥‡®π„π¥â“π«‘Π’μ√«®§—¥°√Õß °“√∫√‘À“√®—¥°“√ Õ’°Σ—Èߧ«√¡’°“√®—¥ √√ß∫ª√–¡“≥„Àâ‡À¡“– ¡‡æ◊ËÕ √â“ß·√ß®Ÿß„®·°àºŸâ∫√‘À“√ ∂“π欓∫“≈ Õ—π®– àߺ≈ μàÕª√– ‘ΣΠ‘¿“æ„π°“√Σ”ß“π¢ÕߺŸâªØ‘∫—μ‘ß“π à߇ √‘¡ ºŸâ„Àâ∫√‘°“√¡’§«“¡°â“«Àπâ“·≈–√—∫º‘¥™Õ∫ß“ππ’È„π √–¬–¬“« ·≈–‡æ◊ËÕ„À₧√ß°“√¡’§«“¡¬—Ë߬◊πμâÕß¡’°“√ ª√–™“ —¡æ—πΠå‡æ◊ËÕ √â“ߧ«“¡√Ÿâ·≈–Σ—»π§μ‘Σ’Ë¥’„π°≈ÿà¡ ºŸâ√—∫∫√‘°“√Õ¬à“ßμàÕ‡π◊ËÕß °‘μμ‘°√√¡ª√–°“» §≥–ºŸâ«‘®—¬¢Õ¢Õ∫§ÿ≥ ”π—°ß“πÀ≈—°ª√–°—π ÿ¢¿“æ ·Ààß™“μ‘ ( ª ™.) ”À√—∫Σÿπ π—∫ πÿπß“π«‘®—¬§√—Èßπ’È Õ¬à“߉√°Áμ“¡Àπ૬ߓπΣ’Ë‡ªìπ·À≈àßΣÿπ¡‘‰¥â√—∫√Õ߇π◊ÈÕÀ“ ·≈–Õ“®¡’π‚¬∫“¬À√◊Õ§«“¡‡ÀÁπΣ’Ë‰¡à Õ¥§≈âÕß°—∫§«“¡ ‡ÀÁπ·≈–¢âÕ‡ πÕ·π–Σ’Ëª√“°Ø„π√“¬ß“ππ’È ¢Õ¢Õ∫§ÿ≥ °√¡Õπ“¡—¬ °√–Σ√«ß “Π“√≥ ÿ¢ Σ’Ë„À⧫“¡Õπÿ‡§√“–Àå ¥â“π¢âÕ¡Ÿ≈·≈–°“√ª√– “πß“π√–À«à“ߺŸâ„Àâ¢âÕ¡Ÿ≈„π à«π μà“ß Ê ¿“¬„π®—ßÀ«—¥μ—«Õ¬à“ß ¢Õ∫§ÿ≥ ”π—°ß“π ∂‘μ‘·Ààß ™“쑄𧫓¡Õπÿ‡§√“–Àå°”Àπ¥°≈ÿà¡μ—«Õ¬à“ß·≈–√–∫ÿæ◊ÈπΣ’Ë ‡ªÑ“À¡“¬ ¢Õ∫§ÿ≥‡§√◊Õ¢à“¬«‘®—¬§≈‘π‘° À ∂“∫—πΣ’Ë‡Õ◊ÈÕ‡øóôÕ ‚ª√·°√¡§Õ¡æ‘«‡μÕ√å„π°“√π”‡¢â“·≈–®—¥°“√¢âÕ¡Ÿ≈ß“π«‘®—¬ 554 Journal of Health Science 2012 Vol. 21 No. 3
18.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ·≈–¢Õ¢Õ∫§ÿ≥𓬷æΣ¬å “Π“√≥ ÿ¢®—ßÀ«—¥ ºŸâª√– “πß“π ºŸâªØ‘∫—μ‘ß“π√–¥—∫®—ßÀ«—¥·≈–√–¥—∫æ◊ÈπΣ’ËΣ—Èß 12 ®—ßÀ«—¥ ‰¥â·°à ®—ßÀ«—¥‡™’¬ß„À¡à ·æ√à æ‘…≥ÿ‚≈° π§√æπ¡ √âÕ¬‡ÕÁ¥ π§√√“™ ’¡“ π§√ª∞¡ ‡æ™√∫ÿ√’ √–·°â« ™ÿ¡æ√ π§√»√’Π√√¡√“™ ·≈–®—ßÀ«—¥ ߢ≈“ Σ’ËÕ”π«¬§«“¡ –¥«°„π°“√≈ßæ◊ÈπΣ’Ë‡°Á∫√«∫√«¡¢âÕ¡Ÿ≈ß“π«‘®—¬ ·≈– ¢Õ∫§ÿ≥ºŸâ„Àâ¢âÕ¡Ÿ≈Σÿ°Σà“π¡“ ≥ Σ’Ëπ’ȥ⫬ «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û ration Network: CRCN); 2010. 10. ”π—° ∂‘μ‘ —ߧ¡ ”π—°ß“π ∂‘μ‘·Ààß™“μ‘. √ÿªº≈Σ’Ë ”§—≠ °“√ ”√«®Õπ“¡—¬‡®√‘≠æ—πΠå æ.». 2552. °√ÿ߇Σæ¡À“π§√: ∫“ß°Õ°∫≈äÕ°; 2553. 11. Glanz K, Rimer BK, Lewis FM. Health behavior and health education: Theory, research and practice. San Fransisco: Wiley & Sons; 2002. 12. Lazcano-Ponce EC, Najera-Aguilar P, Buiatti E, Alonso-de-Ruiz P, Kuri P, Cantoral L, et al. The cer-vical cancer screening program in Mexico: problems with access and coverage. Cancer Causes Control 1997; Sep;8(5):698-704. 13. Phipps E, Cohen MH, Sorn R, Braitman LE. A pilot study of cancer knowledge and screening behaviors of Vietnamese and Cambodian women. Health Care Women Int 1999;20(2):195-207. 14. Boonpongmanee C, Jittanoon P. Predictors of Papani-colaou testing in working women in Bangkok, Thai-land. Cancer Nurs 2007;30(5):384-9. 15. Schulmeister L, Lifsey DS. Cervical cancer screening knowledge, behaviors, and beliefs of Vietnamese women. Oncol Nurs Forum 1999;26(5):879-87. 16. Deschamps M, Band PR, Hislop TG, Clarke HF, Smith JM, To Yee Ng V. Barriers to cervical cytology screen-ing in native women in British Columbia. Cancer De-tect Prev 1992;16(5-6):337-9. 17. Carter J, Park ER, Moadel A, Cleary SD, Morgan C. Cancer knowledge, attitudes, beliefs, and practices (KABP) of disadvantaged women in the South Bronx. J Cancer Educ 2002;17(3):142-9. 18. Lee-Lin F, Menon U, Mooney K. Cervical cancer be-liefs and pap test screening practices among Chinese American Immigarants. Oncology Nursing forum 2007;34(6):1203-09. 19. Steven D, Fitch M, Dhaliwal H, Kirk-Gardner R, Sevean P, Jamieson J, et al. Knowledge, attitudes, be-liefs, and practices regarding breast and cervical can-cer screening in selected ethnocultural groups in North-western Ontario. Oncol Nurs Forum 2004;31(2):305- 11. 20. Hernandez-Avila M, Lazcano-Ponce E, Lopez L, Alonso de Ruiz P, Rojas R. Evaluación del programa de detección oportuna de cáncer cervical in México. Gaceta Médica de México 1994;130:201-9. 21. Mutyaba T, Mmiro FA, Weiderpass E. Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda. BMC Med Educ 2006;1:6-13. 22. Udigwe GO. Knowledge, attitude and practice of cer-vical cancer screening (pap smear) among female nurses in Nnewi, South Eastern Nigeria. Niger J Clin Pract 2006;9(1):40-3. ‡Õ° “√Õâ“ßÕ‘ß 1. World Health Organization. Cervical cancer in devel-oping countries: report of a WHO consultation. Geneva: WHO; 2002. 2. Parkin DM, Whelan SL, Ferlay J, Teppo & Thomas DB. Cancer incidence in five continents Vol. VIII. IARC Scientific Publications [online]. 2003 [cited 2010 Aug 26]; Available from: http://www-dep.iarc.fr/. 3. Sankaranarayanan R. Cervical cancer in developing countries. Trans R Soc Trop Med Hyg 2002;96(6):580- 5. 4. National Cancer Institute. Cancer in Thailand Volume V 2001-2003. In: Khuhaprema T, Sriratanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P, editors. Bangkok: Nation Cancer Institute; 2010. 5. National Cancer Institute. Cervical cancer screening 75 provinces Project (online). 2008 [cited 2010 July 12]; Available from: http://www.nci.go.th/ cxscreening/knowledge.html. 6. Sriamporn S, Khuhaprema T, Parkin M. Cervical can-cer screening in Thailand. J Med Screen 2006;13(Suppl 1):S39-S43. 7. International Health Policy Program Thailand (IHPP) and Health Intervention and Technology Assessment Program (HITAP). Research for development of an optimal policy strategy for prevention and control of cervical cancer in Thailand (online). 2008 [cited 2008 Oct 22]; Available from: http://www.hitap.net/ backoffice/news/pdf_news/2008-09-24_Final-Re-port- Cervica-Cancer.pdf. 8. Π’√– »‘√‘ ¡ÿ¥, √—°¡≥’ ∫ÿμ√™π, ‡™‘≠¢«—≠ ¿ÿ™¨ß§å, À—™™“ »√’ª≈—Ëß, π—¬π“ ª√–¥‘…∞å ‘ΣΠ‘°√, ≈’Ë≈’ Õ‘ß»√’ «à“ß, ·≈–§≥–. °“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥ °√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å (Pap Smear) ·≈– «’‰Õ‡Õ (Visual Inspection with Acetic Acid) „π ª√–‡Σ»‰Σ¬. ππΣ∫ÿ√’: ‚§√ß°“√ª√–‡¡‘π‡Σ§‚π‚≈¬’·≈– π‚¬∫“¬¥â“π ÿ¢¿“æ; 2553. 9. Online Medical Research Tools (OMERET) (com-puter program). ‡§√◊Õ¢à“¬°“√®—¥°“√¢âÕ¡Ÿ≈·≈–™’« ∂‘μ‘ ‡§√◊Õ¢à“¬«‘®—¬§≈’π‘° À ∂“∫—π (Clinical Research Collabo- ııı
Download now